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ABSTRACT

Existing regulatory circuitries govern backbone and acquired host association factors in
the human pathogen Vibrio parahaemolyticus.
By
Jennifer C. Mahoney
University of New Hampshire, May 2011

Vibrio parahaemolyticus is a poorly characterized human gastrointestinal
pathogen whose virulence mechanisms are not well understood. Though closely related
to Vibrio cholerae, V. parahaemolyticus infections are inflammatory and utilize virulence
traits that are unique from the Cholera toxins yet remain poorly characterized. Vibrio
spp. in general share an extensive core genome dedicated to environmental survival and
unique, often horizontally acquired, gene content that is reserved for species specific
lifestyles. This diversity has resulted in a genus of highly specialized bacteria partaking
in dramatically different lifestyles ranging from symbiosis to pathogenesis. We propose
that a comparative genomic and transcriptomic analysis of a conserved host association
regulon (GacA) in the closely related V.fischeri(symbiont) and V. parahaemolyticus
(pathogen), to exploit key lifestyle differences will expose genes that are unique to
pathogenesis. In this study we identified a small, core regulon that is GacA activated
comprised mostly of genes involved in central metabolism. Unique gene content in the
V. parahaemolyticus GacA regulon contained both backbone and horizontally acquired
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elements that were activated or repressed in a highly selective fashion. Temperature was
an important cue in virulence gene activation as determined through phenotypic and
transcriptional assays and acted with GacA in an additive fashion. Specifically,
expression of the classic virulence marker tdh was enhanced in a GacA mutant at 37°C;
however the mutant was defective at initiating an infection in mice potentially
discounting the relevance of TDH in disease. Though TDH is currently accepted as a
clinical identifier, further work may be necessary to confirm a genuine correlation with
disease causing strains. In addition, comparative genomics revealed a significant
reorganization of the GacA regulon in V. parahaemolyticus suggesting that its control has
been uncoupled from quorum sensing circuitry unlike in other characterized regulons.
The GacA regulon of V. parahaemolyticus has undergone subtle regulatory changes
resulting in GacA repression of select horizontally acquired elements and may serve as an
ideal model of the evolution of regulatory networks and the emergence of novel virulence
mechanisms.

CHAPTER I

INTRODUCTION

The family Vibrionaceae is comprised of a diverse group of aquatic organisms
participating in a variety of lifestyles. Dual chromosomes and evidence of extensive
horizontal gene transfer (HGT) in Vibrio have facilitated the expansion of this group to
include related species that occupy unique niches (Okada et al. 2005, Kirkup et al. 2010).
A core "Vibrio" genome allows members of this genus to survive in a general aquatic
ecosystem including estuarine environments of moderate salinity. Occupation by specific
species of more defined niches such as the light organ of a squid, deep-sea hydrothermal
vents, or the gut of a human is thought to be attributed to the horizontal acquisition of
symbiosis genes or virulence genes respectively (Ruby et al. 2005, Makino et al. 2003).
Genomic Plasticity within Vibrionaceae
Although Vibrios share a common evolutionary past, genomic flexibility has
permitted the acquisition of a number of HGT elements that have shaped distinct species
(Kirkup et al. 2010). Viruses that target bacterial cells known as bacteriophage can
transport virulence genes from one bacterial host to another, thereby conferring enhanced
pathogenicity. In Vibrio cholerae for example, the Cholera Toxin genes (ctxAB)
required for virulence, were acquired horizontally in a filamentous phage (Davis et al. 20
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03). Integrons, super-integrons, integrative conjugative elements, transposons, and
plasmid bound genes can all be introduced by bacterial mating or conjugative transfer.
Evidence of these mobile elements can be seen throughout the Vibrio genomes including
super-integrons found in both V cholerae and V. parahaemolyticus, and may contribute
to multi-drug resistance (Rowe-Magnus et al. 2001). Natural competence is rare among
bacteria; however, Vibrio spp. are able to take up naked DNA from the environment
when in the presence of chitin. This unique ability provides additional opportunities for
enhanced host association through the acquisition of new DNA (Meibom et al. 2005,
Yamamoto et al. 2010).
Management of horizontally acquired elements
Once acquired, new DNA must be integrated into existing regulatory networks to
ensure proper expression in coordination with the rest of the genome. Although a variety
of unique regulatory mechanisms exist that direct the expression of ancient genes, the
mechanisms that regulate newly acquired DNA are less clear (Lercher et al. 2008).
Evidence exists to implicate the temperature-sensitive histone-like nucleoid-structuring
protein (H-NS) as a predominant regulatory mechanism for both existing and horizontal
genes (Dorman 2004, Banos et al. 2009, White-Ziegler et al. 2009). H-NS is a globally
acting repressor that appears to target and "police" the expression of new DNA (Atlung et
al. 1997). Upon exposure to a signal, such as increased temperature, H-NS silencing is
relieved and the transcription of virulence genes is activated (White-Ziegler et al. 1998,
Stoebel et al. 2008).
In addition to H-NS silencing, host factor 1 (Hfq), a sRNA chaperone protein,
helps to facilitate communication between the core and variable genomes of several
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gastrointestinal pathogens including Salmonella Typhimurium (Chao et al. 2010). For
example, the horizontally acquired Salmonella Pathogenicity Island-1 encodes an Hfq
target sRNA (InvR) that acts with Hfq to transcriptionally repress the OmpD porin gene
found in the core genome (Pfeiffer et al. 2007, Chao et al. 2010). Additionally, Hfqdependent sRNAs within the core may interact with transcripts of newly acquired genes
to promote their integration into existing regulatory networks (Chao et al. 2010). In this
way, Hfq may help to facilitate harmonious communication and coordinated gene
expression of core and acquired genes.
Distinct Lifestyles of V. fischeri and V. parahaemolyticus
The continuous influx of new genetic elements and ongoing genomic
reorganization in Vibrio spp. has resulted in a genus marked by unique species with
distinctive lifestyles. For example, some Vibrio spp. such as Vibrio fischeri associate
with their hosts in a symbiotic manner (Guerrero-Ferreira et al. 2010). Specifically,
Vibrio fischeri, a bioluminescent marine bacterium, forms a stable, beneficial association
with the Hawaiian Bobtail squid, Euprymna scolopes (Lee et al. 1994). Initiation of this
symbiosis requires V. fischeri to successfully evade a gauntlet of natural host defenses
much like a pathogen (Davidson et al. 2004). Once a small population of cells is able to
migrate through the pores and into the highly specialized light organ, morphological
changes are induced in the host and all other bacteria are excluded (Nyholm et al. 2003).
Successful colonization, growth in the light organ and host signaling/association are all
under the control of the GacS/A global regulator (Whistler et al. 2007).

In contrast, Vibrio parahaemolyticus is a known human pathogen that causes
inflammatory gastrointestinal illness. It is acquired through ingestion of raw or
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undercooked shellfish, typically oysters, and accounts for the majority of seafood borne
illnesses in the U.S. (FDA 2001). Once ingested, V. parahaemolyticus must survive host
immunity, fluctuations in nutrient availability and competition from other organisms.
Successful colonization and pathogenicity in this organism is controlled by the GacA
global regulator much like the host association capabilities of V fischeri (Chapter III).

The GacS/GacA global regulator
Given their large-scale influence on both backbone and acquired genes, conserved
global regulators such as the two-component GacS/A system may play a role in the
regulation of horizontally acquired elements. The membrane bound sensor (GacS) and
its cognate response regulator (GacA) act globally to relieve CsrA mediated repression of
transcripts. When GacS/A is activated, it triggers the production of the sRNA's csrB/C
which competitively bind CsrA relieving repression of transcripts and allowing
translation to proceed (Figure 1.1) (Lapouge et al. 2008).
The GacS/GacA global regulator plays a known role in bacterial host association
and pathogenicity of Vibrio spp. and other gram negative pathogens (Table 1.1. and
Figure 4.1). In Pseudomonas aeruginosa for example, the GacA/GacS regulator is
responsible for multihost virulence contributing to acute infections in both vertebrate and
non-vertebrate hosts (Rahme et al. 2000) as well as chronic infections in a murine model.
Interestingly, host colonization and invasion in the human gastrointestinal pathogens
enteropathogenic Escherichia coli (Bhatt et al. 2009) and Salmonella Typhimurium
(Mizusaki et al. 2008) are both dependent on GacS/A mediated activation of virulence
genes embedded in horizontally acquired elements (BarA/UvrY in Escherichia coli and
BarA/SirA in Salmonella Typhimurium). In Vibrio cholerae and Vibrio vulnificus,
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mutations in GacS/GacA (VarS/VarA in Vibrio cholerae) results in decreased production
of virulence factors such as the Cholera Toxin, proteases and cytotoxic proteins and
ultimately attenuation of virulence in mice (Wong et al. 1998, Jang et al. 2010, Gauthier
et al. 2010). In addition to pathogenic interactions, GacS/A is an important regulator of
general host-microbe interactions including symbiotic relationships. Vibrio fischeri for
example, requires GacA to establish a beneficial association with its squid host,
Euprymna scolopes. Specifically, a GacA mutant in this organism is unable to initiate
and maintain an infection of the light organ, possibly as a result of defective production
of the specific symbiosis factor bioluminescence (lux) (Whistler et al. 2003). This
highlights that GacS/GacA is an important regulator not only of pathogenic associations,
but of host-microbe interactions in general. Given that host specificity and association
traits are often the result of horizontally acquired genes, it is reasonable to consider the
GacS/A system as a potential regulatory control mechanism of newly acquired host
association genes.
Unique and Shared Characteristics of Distinct Host Associations within Vibrio
Despite the unique outcome of their respective host associations, V fischeri and
V. parahaemolyticus share several interesting similarities in gene content and host
environment. For example, the light organ of the squid is lined with polarized epithelial
cells whose brush borders resemble those of the human gastrointestinal tract. Once
colonized with V.fischeri,predictable changes to the host microvillar surfaces mimic
those seen in pathogenic infections of the human gut (Lamarcq et al. 1998) and may be
the result of either host or bacterial induced B-actin reorganization (Lamarcq et al. 1998,
Aktories et al. 2011). Indeed both V.fischeriand V. parahaemolyticus contain a toxin
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termed RTX (repeats in toxin) that is involved in the reorganization of B-actin in human
gut epithelial cells (Ruby et al. 2005, Makino et al. 2003). This well characterized toxin
has known roles in virulence in V cholerae and V. vulnificus making its presence in the
non-pathogenic V fischeri all the more note-worthy (Fullner et al. 2000, Liu et al. 2007).
In fact, RTX is only one of several toxin genes found in V fischeri. Others include
hemolysin genes, CNF (cytotoxic necrotizing factor), ace (accessory cholera enterotoxin),
and zot (Zonula occludens toxin) highlighting that, if functional, these "toxins" are more
likely related to host-association rather than virulence per se (Ruby et al. 2005). In
addition, pathogenic infections are typically marked by an immediate morphologic
response to the presence of the pathogen such as membrane ruffling in Salmonella
Typhimurium (Finlay et al. 1991) and the attachment and effacement of host brush
borders in Escherichia coli (Finlay et al. 1992). Alterations to the squid light organ are
not as immediate and tend to be observable over several days of colonization. These
slower changes are akin to commensal associations and chronic infections of the human
gut and their study may shed light on the contribution of single species colonization in a
host (Lamarcq et al. 1998).

Despite similarities seen in V fischeri and gut pathogens including V.
parahaemolyticus, V fischeri ultimately forms a beneficial relationship with its host.
Historically, unique genes acquired horizontally have been theorized to confer distinctive
host association properties such as symbiosis or pathogenesis. However, the presence of
several toxins in V.fischeriand its resultant lack of virulence have forced us to consider
alternative possibilities. Conserved core genes may play more of a role in host species
specificity than previously thought, or perhaps gene content alone may not be enough to
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explain differing lifestyles. It is possible that unique gene regulation or global regulatory
patterns of core genes may account for specific, highly specialized lifestyles. Ultimately,
it may not be what they have but how they use it that defines the outcome of Vibrio host
associations.

Objectives and Goals

Chapter I: What defines virulence in Vibrio parahaemolyticus?

Hypothesis: In addition to unique genome content, specific regulatory responses of core
and acquired genes to host cues are required for virulence.

Approach: Compared known pathogenic strains of V. parahaemolyticus to
environmental isolates in a suite of virulence-associated phenotypes at both
environmental and human host temperatures (28°C and 37°C respectively) to identify
group specific trends.

Chapter 2: Do the novel virulence mechanisms of V. parahaemolyticus represent an
evolutionary re-wiring of the conserved GacA pathway?

Hypothesis: Virulence mediated by both core and horizontally acquired genes in V.
parahaemolyticus is dependent upon the GacS/GacA pathway.

Approach: A mutation in gacA was generated and examined for defects in virulence
associated phenotypes consistent with gacA mutations in other organisms. In addition,
microarray analysis was performed at both 28°C and 37°C to examine this regulon at
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both environmental and human host temperatures and comparatively with previously
characterized gacA regulons.

Chapter 3: Are horizontally acquired elements incorporated into existing
regulatory networks that have known roles in host association in Vibrio spp.?

Hypothesis: Comparative analysis of the GacA host association regulons in a pathogen
and symbiont (V parahaemolyticus and Vfischeri) will reveal lifestyle specific gene
content and regulatory patterns.

Approach: Microarray analysis of wild type and a gacA mutant regulons was performed
in both organisms (V. parahaemolyticus at human body temperature 37° and Vfischeri at
28°C, as close to squid temperature (23°C) as can be maintained in the laboratory). A
core "Vibrio" genome was identified as was unique gene content in each organism under
GacS/GacA control. The potential for a gene(s) to have been acquired through horizontal
gene transfer was assessed informatically based on %GC content, dinucleotide bias and
the presence of mobility genes.
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Table 1.1. Summary of GacA regulons in other bacteria
Organism
Vibrio
fischeri
c
cholerae
harveyi
^vulnificus
Erwinia
carotorva
chrysanthemi
'sSalmonella
Escherichia
coli
Legionella
pneumophila
fl
Pseudomonads
Pseudomonas
aeruginosa

Altered
Host
Quorum
Motility Iron Protease Biofilm Associatior Sensing8 Cytotoxicity

X

X

X

X
X (T3SS)
X (T3SS)
X

-

X
X

X
X (T3SS)

X

X

X

X
-

X

X

X

X

X

X
X

X

X

X

X
X

X
X
X

X*

X

-

X
X
X (T3SS)

X

X

X

X

Blank spaces denote "not evaluated"
- not influenced by GacA
X influenced by GacA
a
A GacA mutant of Vibrio fischeri had a very modest (and not considered biologically
relevant) influence on AHL signal production, though microarrays show a general
integration of GacA with Quorum Sensing.
Adapted from bWhistler et al. 2003 and Chapter IV, cWong et al. 1998, Jang et al.
2010 and Tsou 2011, dHenke et al. 2004 and Lenz et al. 2005, 'Gauthier et al. 2010
f
Lapouge et al. 2008, gGoodier et al. 2001 hBhatt et al. 2009.
'Summary of the following species: chlororaphis (aureofaciens),entomophila,
fluorescens, marginalis syringae pv.,syringae, syringae pv. Tomato, tolaasii,
viridiflava
* APPENDIX II
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Figure 1.1. Model of GacA mediated translational regulation (adapted from Ballok 2007).
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CHAPTER II

COMPARISON OF THE PATHOGENIC POTENTIALS OF ENVIRONMENTAL
AND CLINICAL VIBRIO PARAHAEMOLYTICUS STRAINS INDICATES A ROLE
FOR TEMPERATURE REGULATION IN VIRULENCE

Although the presence of pathogenic Vibrio spp. in estuarine environments of
northern New England has been known for some time (Bartley et al. 1971, O'Neil et al.
1990), their virulence and the relative threat they may pose to human health has yet to be
evaluated. In this study, the virulence potential of 33 Vibrio parahaemolyticus isolates
collected from the Great Bay Estuary of New Hampshire was assessed in comparison to
that of clinical strains. The environmental isolates lack thermostable direct hemolysin
(TDH) and TDH related hemolysin (TRH), which are encoded by tdh and trh,
respectively. Though not hemolytic, they do possess putative virulence factors, such type
III secretion system 1, and are highly cytotoxic to human gastrointestinal cells. The
expression of known and putative virulence-associated traits, including hemolysin,
protease, motility, biofilm formation, and cytotoxicity, by clinical reference isolates
correlated with increased temperature from 28°C to 37°C. In contrast, the environmental
isolates did not induce their putative virulence-associated traits in response to a
temperature of 37°C. We further identified a significant correlation between hemolytic
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activity and growth phase among clinical strains, whereby hemolysin production
decreases with increasing cell density. The introduction of a tdhv.gfp promoter fusion
into the environmental strains revealed that they regulate this virulence-associated gene
appropriately in response to temperature, indicating that their existing regulatory
mechanisms are primed to manage newly acquired virulence genes.
Despite relatively cool water temperatures, estuarine environments in northern
New England are a known niche for pathogenic species of the genus Vibrio (Bartley et al.
1971, O'Neil et al. 1990, Striplin et al. 2008). Shellfish beds within these habitats serve
both as a natural reservoir where Vibrio spp. accumulate and as vectors for human
infection. Recent outbreaks of Vibrio parahaemolyticus in NewYork, New Jersey,
Connecticut, Washington, and Alaska highlight the importance of further research to
understand the resident strains in these potentially significant habitats for this emergent
pathogen (CDC 2006, McLaughlin et al. 2005, Nolan et al. 1984).
Infections by V. parahaemolyticus are often acquired through the ingestion of raw
or undercooked shellfish, including oysters. Upon colonization of the intestine, the
products of the hemolysin genes (tdh and trh, encoding thermostable direct hemolysin
[TDH] and TDH-related hemolysin) are believed to rapidly induce inflammatory
gastroenteritis (Honda et al. 1993, Raimondi et al. 1995, Shiraih et al. 1990). Recently, a
more infectious pandemic serotype (03 :K6) emerged that is often identified by the
presence of the ORF8 gene (Hurley et al. 2006). Not all strains of V. parahaemolyticus
are human pathogens. Historically, acquisition by horizontal gene transfer (HGT) of the
tdh gene within Vibrio pathogenicity island-7 (VPaI-7) (Makino et al. 2003) and/or the
trh gene within the recently identified Vp-PAITH3996 (Okada 2009) has been credited

12

with the transition from non-infectious environmental to human pathogenic clinical
strain. However, V. parahaemolyticus remains pathogenic even in the absence of these
two thermostable hemolysins, indicating that other virulence traits exist (Nishibuchi et al.
1992, Park et al. 2000, Xu et al. 1994). Furthermore, recent outbreaks have been caused
by strains lacking tdh and/or trh (Garcia 2009). Although other virulence factors have
been investigated, including type III secretion systems 1 and 2 (T3SS1 and T3SS2) and
biofilm formation, the understanding of virulence remains incomplete (Hurley et al. 2006,
Tamayo et al. 2010). Moreover, the contribution to pathogenicity of conserved virulenceassociated factors present in a wide range of bacterial pathogens (e.g., protease,
siderophore, and motility), the ability to regulate newly acquired virulence factors, and
the capacity to adjust to a human host environment have yet to be revealed.
In order to assess the virulence potential of environmental V. parahaemolyticus
isolates lacking the characteristic tdh/trh hemolysin genes, we examined their ability to
express alternative, conserved virulence-associated factors at environmentally relevant
and human body temperatures. The "environmental" strains in this study were isolated
from environmental samples and have further been defined by the absence of either tdh or
trh, whereas "clinical" strains were isolated either from patients or from the environment
during an outbreak and harbor tdh and/or trh genes. Among the clinical strains examined,
we found a strong correlation of the production of potential virulence-associated factors
with human body temperature and an inverse correlation of hemolysin with cell density.
In contrast, the environmental strains do not express their conserved virulence-associated
traits in response to body temperature, but many of the environmental isolates were
highly cytotoxic to human gastrointestinal cells. In addition, the environmental isolates
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lack the tdh gene but were able to express this gene's promoter appropriately in response
to a temperature of 37°C. Although these environmental isolates are unlikely to cause a
human infection, they do represent a population of bacteria whose existing regulatory
networks can appropriately control newly acquired virulence genes.

MATERIALS AND METHODS
Bacterial strains and culture conditions. Thirty-three environmental strains of
Vibrio parahaemolyticus isolated from New Hampshire's Great Bay Estuary from May
through December 2007 (Striplin et al. 2008) were used in this study, along with an
additional two strains from other sources (Table 2.1). All New Hampshire isolates were
negative for both tdh and trh based on multiplex PCR analysis (Panicker et al. 2004,
Striplin et al. 2008). The presence of various other proposed virulence genes, including
T3SS2 apparatus gene vscC2 and effector vopP, a putative DNA methyltransferase, a
homolog of the Escherichia coli cytotoxic necrotizing factor vopC, and a homolog of
V.cholerae pathogenicity island gene VPA1376, was determined by PCR with published
methods (4). A prepandemicraTz-positivestrain, BB22, was used as a reference, and nine
clinical strains from outbreaks worldwide were used for comparison (Table 2.1).
Bacteria were grown in heart infusion (HI) medium at a pH of 7.3 (Fluka, Buchs,
Switzerland) at 28°C, a temperature often used to cultivate many environmental
Vibrio spp., and 37°C, human body temperature, for all phenotypic assays. Uniform
growth patterns were observed for environmental and clinical strains grown in rich
medium, as determined from growth curves in HI medium at 28°C and 37°C using a
Tecan infinite M200 plate reader (Mannedorf, Switzerland) for 24 h. For experiments
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measuring tdh promoter activity, plasmid pVCWIOCI was maintained by the addition of
chloramphenicol (CHL) at a final concentration of 25 ug/ml. Triparental matings were
performed on super optimal broth (SOB) plates containing 2% Bactotryptone, 0.5% yeast
extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgC12, 10 mM MgS04, and 1.5% agar at
37°C for 12 h, and outgrowth was performed on HI-CHL at 28°C. For quantitative
hemolysin assays conducted in conditioned broth, strain BB22 was grown to an optical
density at 600 nm (OD600) of 1.0, the cells pelleted by centrifugation and discarded, and
the cleared broth filter sterilized. Strains were inoculated into a 1:1 mix of rich HI
medium and BB22 cell-free supernatant.
Characterization of virulence-associated phenotypes. All phenotypic
characterization assays were conducted a minimum of three times. Plate assays were
conducted for motility, protease, and siderophore in cultures grown in HI with shaking
and then standardized to an OD600 of 0.5 prior to inoculation. Throughout our phenotypic
characterization experiments, the OD600 was often determined from 150ul of culture in a
96-well plate, and the value converted to a standard OD600 per ml based on an empirically
determined conversion factor so that our data would be comparable to those of other
studies. Motility was measured using 25-ml soft agar plates containing 10 g tryptone, 20
g NaCl, and 3.35 g Bacto agar per liter as previously described (Jaques 2006). The plates
were inoculated with 2 ul of each isolate in triplicate. After 24 h, the diameter of the zone
of bacterial migration was measured in millimeters. Protease production was assessed
with HI plates to which 4 g/liter sterilized skim milk was added following autoclaving
and cooling to 50°C. The plates were inoculated in triplicate with 5ul of each isolate. A
positive result was indicated by a clearing around the inoculum after 24 h. Siderophore
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production was determined from cultures spotted onto artiflcial-seawater-based chrome
azurol S (CAS) agar buffered with 100 mM PIPES [piperazine-Af,Ar-bis(2-ethanesulfonic
acid)], pH 6.8 (Payne 1994). A positive result was indicated by an orange halo around
siderophore-producing cells. Hemolytic activity was determined qualitatively using
Wagatsuma agar (Miyamoto et al. 1969). Cultures were grown either to mid-log or
overnight, and 5ul amounts were spotted on the plates in triplicate. Plates were examined
at 24 h, and a betahemolytic clearing around the colony indicated a positive result.
Biofilm assays were performed according to a standard protocol (O'Toole et al.
1999), with slight modifications. Strains were inoculated into 200 ul of HI medium per
well of a polystyrene microplate (Costar, St. Louis, MO) and grown for 4h at either 28°C
or 37°C with shaking at 200 rpm. Four hours was empirically determined to be the point
at which biofilm could be reliably measured without biofilm "clumps" releasing from the
glass tube and introducing significant variation. The OD595 was determined for baseline
optical density. The cultures were then expelled from the plate, which was washed twice
with 200 ul of distilled water per well. The plates were allowed to dry, and then the cells
were fixed at 80°C for 30 min. Following staining with 0.1% crystal violet for 20 min,
the wells were destained with 200 ul 95% ethanol. The OD595 was measured, and the
biofilm quantified as absorbance normalized to the cell density of the initial culture
(OD6oo)- When cultures were grown for more than 4 h, the biofilm production was so
great that clumped cells were sometimes expelled with the medium, making biofilm
measurements highly variable.
A quantitative hemolysin assay was adapted from a previously published assay
(Fan et al. 2001). In brief, 150 ul amounts of cultures taken throughout the growth cycle
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were combined with 800 ul of a blood mix of 40 ml of IX phosphate-buffered saline
(PBS) plus 500 ul defibrinated sheep blood (Northeast Laboratories Services, Winslow,
ME), and cells were pelleted by centrifugation at 9,000 rpm (6,605Xg) for 4 min. The
tubes were incubated for 18 h, and the cell wall debris removed by centrifugation at
13,000 rpm. The amount of heme present in cleared cell lysate as determined by the
OD415 was used as a measure of red blood cell lysis and normalized to the bacterial cell
density (OD6oo)In order to determine the potential role of late-growth-phase extracellular or cellassociated proteases in the degradation of hemolysins, we performed a time course
hemolysin assay with exposure to either late-phase cell-free supernatant or sonicated
whole cells. Strain MDOH-03-17282-Vp was grown to an OD600 value of 1.0, when
hemolysin is optimally produced, and an OD600 value of 2.5, when hemolysin activity
was substantially decreased. The cells were pelleted, and the supernatants were purified
with a 0.2um polyethersulfone filter (VWR, West Chester, Pennsylvania). The cell pellet
was then sonicated in 1 ml of sterile IX PBS to release cell-associated proteases. The
supernatant or sonicated cells were then combined with 1 ml of extracted hemolysin, and
hemolytic activity against blood mix was assayed as described above every 30 min for 3
h. as a control, cell-free hemolysin was also incubated in HI.
Cytotoxicity assays were developed using a human gastrointestinal epithelial cell
line (CaCo-2) grown in Eagle's minimal essential medium (Mediatech, Inc., Herndon,
VA) modified with HEPES (J.T.Baker, Mumbai, India) and supplemented with 0.7%
Leibovitz's L-15 (Mediatech, Inc., Herndon, VA), 0.03% L-glutamine (Lonza, Basel,
Switzerland), 0.08% sodium bicarbonate (J.T.Baker,Phillipsburg, NJ), 1% nonessential
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amino acids (Thermo Scientific HyClone,Logan, UT), 10% fetal bovine serum (Lonza,
Basel, Switzerland), and 1% penicillin-streptomycin-amphotericin B (100X) (Lonza,
Basel, Switzerland) at a pH of 7.0 with no CO2. Preliminary experiments were conducted
to determine the optimal multiplicity of infection (MOI), using strain BB22 as a positive
control, because it was previously determined to be highly cytotoxic (L. L. McCarter,
personal communication), and HI broth as a negative control. Exposure to each V
parahaemolyticus strain, grown overnight with shaking at an MOI of 100, was
carried out in triplicate in a 384-well plate. Following incubation for at least 5 hours at
37°C with no CO2, the relative cytotoxicity was measured by lactate dehydrogenase
release, quantified by using a Cytotox-Fluor cytotoxicity assay, following the
manufacturer's protocols (Promega, Madison, WI), and read on a Tecan Infinite M200
plate reader. The experiment was conducted four times. Each experiment had low withinexperiment variability, and the data from one representative experiment are presented.
Analysis of significance of differences in cytotoxicity and correlations of
phenotypes with temperature using replicate experiments were conducted by oneway
analysis of variance (ANOVA) using the statistical software SPSS (SPSS, Inc., Chicago,
IL).
Expression of tdh. To measure tdh gene expression, a tdhv.gfp promoter fusion
was generated by splicing-by-overlap extension (SOE)-PCR following published
protocols (Horton 1990), using the Expand long template PCR system (Roche Applied
Science, Indianapolis, IN). The outer forward primer (tdhFl, TATGTCGACCAGATT
TCTCGCTTGTGC) was designed to the tdh gene (VPA1314) from the RIMD2210633
published sequence. The outer reverse primer (gfpRl, TATCTGCAGGTTGTACAGT
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TCATCCATGC) was designed to the gfp gene from pQBI63 (Quantum Biotechnology,
Montreal, Canada). Internal forward and reverse SOE primers were designed to fuse the
gfp gene to the tdh promoter at its ribosomal binding site, ensuring correct spacing of the
gene within the transcript (tdhSOEF6, AAGTTATTAATCAATTCAGAGGAG
GAGAATACTAATGGC, andtdhSOER6, GCCATTAGTATTCTCCTCCTCTGAATTG
ATTAATAACTT). The first PCR amplicons were generated with primers tdhFl and
tdhSOER6 using strain BB22 as a template and with tdhSOEF6 and gfpRl using
pVSV102 as a template for gfp (Dunn 2006), and the second round of SOE was
performed with the outer primers (tdhFl and fgpRl) only. The amplicon was
directionally cloned into the low-copy-number plasmid pVSV105 (Dunn 2006) so that
expression was driven by the native tdh promoter only. The newly generated construct
(pVCWIOCI) was then introduced into strains BB22, DAL1094, MDOH-03-17282-Vp,
MDOH-04-5M732, KE9967, Gl, G91, and G145 by conjugation.
The expression of the tdh gene was determined throughout the growth cycle of
each strain inoculated in quadruplicate into 150ul HI-CHL in the wells of a clear-bottom
black polystyrene microplate (Costar, St. Louis, MO) and grown at either 28°C or 37°C
for 24 h. At each time point, the OD600 was used to determine cell growth, and tdh
expression was determined by emission at a wavelength of 515 nm following excitation
at a wavelength of 480 nm using a Tecan Infinite M200 plate reader with a manual gain
of 175. The background fluorescence produced by reference strain BB22 was subtracted
from each value, and the fluorescence normalized to the OD600. Upon determination of
the induction profile of gfp in each strain, a single post-induction time point (OD600 = 1)
was chosen for direct comparison between strains at each temperature.
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RESULTS AND DISCUSSION
Although the environmental strains examined in this study were confirmed to lack
the tdh/trh virulence-associated genes, we further genotypically characterized these
strains for five genes putatively involved in virulence, as previously described, most
notably in other environmental isolates without the classical virulence markers tdh and
trh (Caburlotto 2009). Although none harbored the putative T3SS2 effector protein vopP,
some strains were positive for a gene involved in its secretory apparatus, as well as a
homolog of a gene found within a Vibrio cholerae pathogenicity island (Table 2.1).
Despite the presence of one or more of these putative virulence genes in a small subset of
environmental strains, which could prove to be relevant to their virulence potential, this
cohort did not display enhanced or altered virulence patterns in the phenotypic
characterization assays. This may be the result of genes that are present in a genome but
not functionally expressed or, possibly, a lack of connection between these putative
virulence genes and the phenotypes for which we screened.
The environmental strains did show evidence of more conserved virulenceassociated mechanisms, such as motility and biofilm, siderophore, and protease
production (Luan et al. 2007, Tamayo et al. 2010, Tsou et al. 2008, Wang et al. 2010).
Specifically, the environmental and clinical strains were motile and produced
extracellular proteases, biofilm, and siderophore at both 28°C and 37°C (Table 2.S1).
Unlike the environmental isolates, the clinical group showed a notable difference in
response to the human host temperature of 37°C (Table 2.2). In particular, we observed a
significant increase in motility and in biofilm and protease production (1.2, 9 and 4 fold
change respectively) at 37°C compared to the results at 28°C in the clinical strains,
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whereas the environmental isolates showed no significant difference in motility or
biofilm production and showed a significant decrease in protease production at 37°C.
Further underscoring the difference between the environmental and clinical strains, a
direct comparison of each population at 37°C indicates that the environmental group
produces significantly less protease (P> 0.001) and less biofilm (P =0.02) than the
clinical group, although due to high variability among strains, they were not significantly
different in motility. Siderophore was detected in all strains at both 28°C and 37°C, with
the exception of the reference strain BB22 (Table 2.SI). Although siderophore
production in other Vibrio spp., specifically Vibrio (Aliivibrio) salmonicida, has been
observed only in response to disease-permissive temperatures (Colquhoun et al. 2001),
the production of siderophore by V.parahaemolyticus at both temperatures indicates that
it may play a role both in infection and in environmental fitness or may simply be
required for general survival.
Bacterial pathogens that oscillate between the natural habitat and a mammalian
host commonly utilize environmental cues to coordinate virulence-associated gene
expression (Roux et al. 2009). Though a variety of signals exist within the human host,
temperature has been implicated as an important activator of virulence gene expression in
several gastrointestinal pathogens, including Shigella spp., Yersinia spp., and pathogenic
Escherichia coli (Herbst et al. 2009, Maurelli et al. 1984, Olsen et al. 1998). Pathogenic
Shigella spp., for example, are unable to successfully penetrate human epithelial cells and
have attenuated virulence at 30°C that is fully restored upon a temperature increase to
37°C (Maurelli et al. 1984). Furthermore, Vibrio parahaemolyticus strains that are
positive for the virulence-associated gene urease exhibit an increase in urease expression
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at 37°C compared to its expression at 30°C (Park et al. 2009). The specific response of
virulence phenotypes, including hemolysin (Table 2.SI), to host temperature seen in this
study may be reflective of the fundamental regulatory differences between environmental
and clinical strains. This unique regulatory switch could provide a selective advantage in
the human host environment, promoting infection and disease. Despite the presence of
some functional virulence-associated factors in the environmental population, the strains
are apparently unable to coordinate the production of these factors in response to this host
cue. The data presented herein supports previous work implicating temperature
dependent regulation in the appropriate expression of putative virulence genes in other
bacterial pathogens and further clarify the differences between environmental and clinical
strains of V.parahaemolyticus (Herbst et al. 2009, Maurelli et al. 1984, Olsen et al. 1998,
Park et al. 2009).
Cytotoxicity toward human gastrointestinal cells is widely used to assess bacterial
virulence and was used here to assess the virulence of both clinical and environmental
strains (Hiyoshi et al. 2010). Clinical isolates of V. parahaemolyticus contain a
conserved T3SS1 (Makino et al. 2003) and horizontally acquired genes, including tdh and
T3SS2 (Kodama et al. 2007, Park et al. 2004), that are known to contribute to the lysis of
epithelial cells through disruption of cytoskeletal structures and a loss of membrane
integrity, possibly leading to secretory diarrhea (Caburlotto et al. 2010, Nishibuchi et al.
1992). The clinical strains all displayed significant cell lysis ability at both 28°C and
37°C, which perhaps implies that this mechanism is important both in the natural
environment and during human infection (Figure 2.1(A)). In comparison, the majority of
environmental strains were as cytotoxic as a reference strain at 37°C but had overall
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increased cytotoxicity at 28°C (Figure 2.1(B)). The upregulation of a virulence
mechanism at a more environmentally relevant temperature further conflicts with the
behavior of the virulent clinical strains. Strains G91 and G149 represent a small subgroup
of environmental isolates that showed a different trend, with low cytotoxicity at both
temperatures (Figure 2.1 (B)). The elevated cytotoxicity seen in the environmental group
in response to a cooler temperature (28°C) may imply the utility of cytotoxicity in the
natural environment, perhaps during interactions with a eukaryotic marine host.
However, the high level of cytotoxicity in environmental strains may also indicate that
cytotoxicity is not an accurate measure of the virulence capacity of a given strain of V.
parahaemolyticus and that the development of other in vitro or in situ models is critical
for understanding the pathogenic capability of this emergent pathogen.
Unlike the conserved, virulence-associated traits we investigated in both
environmental and clinical strains, the putative virulence factor hemolysin is likely the
result of horizontal acquisition of the tdh gene on Vibrio pathogenicity island-7 (Chun et
al. 1975, Myers et al. 2003) and/or the trh gene on Vp-PAITH3996,. These pore-forming
toxins are solely responsible for the Kanagawa phenomenon that is the defining
characteristic of many clinical strains (Chun et al. 1975). The environmental isolates
used in this work lacked tdh and trh (Table 2.1), and as expected, they showed no
hemolytic activity at either 28°C or 37°C on Wagatsuma agar (Table 2.S1) (Miyamoto et
al. 1969). The clinical strains were not hemolytic at 28°C but were strongly hemolytic at
37°C (Table 2.SI). Although no comprehensive study has been completed on temperature
regulation of hemolysin in V. parahaemolyticus, some observations have been made as
part of other studies. For instance, V. parahaemolyticus induced to the viable but
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nonculturable state by cold and then exposed to temperature upshifts to 37°C did not
show tdh expression (Coutard et al. 2007), but heat shock at 42°C did induce TDH
production in a separate study (Chiang et al. 2008). The dramatic response of this
putative virulence phenotype to human host temperature across a group of diverse clinical
strains agrees with its role in pathogenesis and provides us with new insights about host
cues, specifically temperature, involved in hemolysin activation.
In addition to activation in response to increased temperature, hemolysin
production correlated inversely with culture density (Figure 2.2). Specifically,
hemolysins are present at high levels during early log phase and decrease as the ODgoo
increases. Virulence gene repression at high densities in both Vibrio harveyi and Vibrio
parahaemolyticus is known to result from quorum-sensing regulation (Henke et al. 2004).
In order to assess the possible involvement of quorum sensing in the decrease of
hemolysin during late growth phase, hemolysin assays were completed with cultures
grown in medium conditioned with cell-free supernatants from late-log-phase cultures of
the reference strain BB22. We anticipated that if the repression of hemolysin was in
response to quorum-sensing signals that accumulate in the medium, then hemolytic
activity would decrease more rapidly in conditioned broth. We saw no effect on
hemolysin production (data not shown), indicating that hemolysin regulation is likely the
result of a cue(s) separate from quorum sensing. Next, we examined the transcription of
tdh using a tdhv.gfp promoter fusion normalized to cell density, which showed no decline
in expression as cell density increased but, rather, showed a plateau in expression,
supporting the idea that the decrease in hemolysis was not transcriptional (data not
shown).
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Finally, we tested the role of extracellular and/or cell-associated proteases in
hemolysin degradation. Complete loss of hemolysis was achieved after incubation with
late-log-phase cell-free supernatants (data not shown), indicating^that proteolysis is the
likely mechanism of hemolysin turnover.
Not only do the environmental strains lack the tdh/trh putative virulence genes,
but they also lack the ability to regulate other conserved virulence-associated traits in
response to human body temperature. The underlying questions of how existing and
acquired virulence genes are appropriately regulated in response to temperature and,
more specifically, whether this regulation is ancient or obtained horizontally with
acquired virulence genes remain unanswered. We addressed this question by introducing
a tdhv.gfp promoter fusion into various environmental and clinical strains and assessing
the activity of the promoter at the two experimental temperatures. Green fluorescent
protein (GFP) was only detected above background levels at 37°C and not at 28°C
degrees in all environmental and clinical strains tested (Figure 2.3). The early induction
of GFP in all strains by the time the OD600 reached 0.5 and the rapid plateau of GFP by
the time the OD600 reached 1.0 are in agreement with the hemolysin phenotype seen in
the quantitative assays (Figure 2.2) and could reflect the importance of TDH in early
infection and colonization. Virulence traits that are acquired horizontally must be
regulated in coordination with the rest of the genome in order to confer enhanced
pathogenicity. During the transition from an environmental setting to a host environment,
the bacterial cell must integrate an assortment of signals and respond with appropriate
activation or repression of both conserved and newly acquired genes. Although a variety
of unique regulatory mechanisms exist that direct the expression of ancient genes, the
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mechanisms that regulate newly acquired HGT components are less clear (Lercher et al.
2008). In recent years, a body of evidence has grown showing that a predominant
regulatory mechanism for both existing and horizontal genes is the temperature-sensitive
histone-like nucleoid-structuring protein (H-NS) (Banos et al. 2009, Dorman et al. 2004,
White-Ziegler et al. 2009). H-NS is a globally acting repressor that appears to target and
"police" the expression of new DNA (Atlung et al. 1997). Upon exposure to a signal,
such as increased temperature, H-NS silencing is relieved and the transcription of
virulence genes is activated (Stoebel et al. 2008, White-Ziegler et al. 1998). Given that
the tdh gene is located within a horizontally acquired pathogenicity island (Hurley et al.
2006) and is induced at higher temperatures, H-NS silencing is a probable mechanism for
the temperature-dependent expression we observed. If all virulence phenotypes are under
the regulatory control of H-NS, then the disparity between environmental strain
regulation of tdh but not conserved virulence-associated traits in response to temperature
indicates that the regulation of virulence is more complex, perhaps suggestive of different
niche adaptations.
Since the majority of the environmental strains in this study were isolated from
the same cooler Northern population, it is possible that the temperature dysregulation we
observed in environmental strains is unique to this population. It is, however, notable that
the one clinical strain isolated from Washington, also a cooler climate, did trend more
closely with the clinical strains and not with the cool-water environmental strains (Table
2.S1), supporting the hypothesis that temperature regulation is an attribute of clinical
strains. Still, the two environmental strains isolated from warmer climates (both of which
were environmentally isolated but associated with an outbreak) did show some
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temperature regulation similar to that in the clinical group (Table 2.S1). A broader
sampling of environmental strains will be necessary to fully address the question of
whether northern strains are unique in their regulation or if this trait is specific to isolates
from the Great Bay Estuary. Ultimately, temperature regulation could still be an
important consideration in determining the virulence potential of strains from such
climates.
Although the environmental strains do not contain tdh or the VPaI-7 island, they
do have the capacity to regulate tdh in response to an increase in temperature and growth
phase. Thus, the regulatory mechanisms involved in managing newly acquired virulence
elements are present even in nonclinical strains of V. parahaemolyticus. This provides
evidence that the control of new virulence genes is ancient and that horizontally acquired
components are incorporated into existing regulatory networks for proper expression.
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TABLE 2.1. Bacterial strains with relevant pathogenicity markers
Strain
Clinical
BB22

Origin
Reference strain
Waterb (India)
Patient (USA, FL)
Patient (Japan)
Patient (USA, FL)
Patient (Japan)
Patient (USA, TX)
Clinical (India)
Patient (USA, FL)
Patient (USA, NY)
Clamb (USA, WA)

tdh

trh

+

-

ORF8a vscC2 vopP MTase vopC
-

+

+

MDOH-03-17294-Vp
+
+
+
AQ4037
+
+
MDOH-03-17282-Vp
+
+
+
KE9967
+
+
+
TX2103
+
+
+
+
+
+
+
VP81
MDOH-04-5M732
+
+
+
+
BAC98-03255
+
+
+
+
+
+
+
+
+
F11-3A
Environmental
EnvDOH-04-001
Oyster (USA, FL)
DAL1094
Oysterb(USA,TX)
+
G46,G151,G227
Oyster (USA, NH)
+
Water (USA, NH)
G246, G69
+
G10,G31,G43,G91, Oyster (USA,NH)
+
G251
+
Water (USA, NH)
G149
+
G26
Clam (USA, NH)
G74, G95, G237
Oyster (USA,NH)
G1,G7,G23,G242
Oyster (USA, NH)
Water (USA, NH)
G4, G6, G8, G235
Mussel (USA, NH)
G25
G12, G13, G79, G145, Oyster (USA, NH)
G259, G277
G61, G62, G255
Water (USA, NH)
a
associated with pandemic isolates; associated with outbreak; c provided by EF
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VPA1376 Source

+

+

+

(McCarter 1998)

+
+
+
+
+
+

+
+
+
+
+
+
+

+
+
+
+
-

(Davis 2007)
(DePaola 2003)
(Davis 2007)
(Osawa 2002c)
(DePaola 2003)
(Martinez-Urtaza 2004°)
(Davis 2007)
(Myers 2003)
(DePaola 2003)

+
+
+

(Stripl in 2008)
(Stripl in 2008)
(Stripl in 2008)
(Stripl in 2008)
(Stripl in 2008)

+
+
+

+
+
+
+
+

(Striplin 2008)
(Striplin 2008)
(Striplin 2008)
(Striplin 2008)
(Striplin 2008)
(Striplin 2008)
(Striplin 2008)
(Striplin 2008)

Boyd.

TABLE 2.2. Phenotypic characterization of the environmental and clinical groups
Clinical Isolates from Outbreaks
Phenotype

Effect of temperature shift (28° to 37°)

Motility

Significant increase at 37°

1.2

O.0001

Biofilm

Significant increase at 37°

9

0.01

Siderophore

No trend observed

0

-

4

0.001

Fold A

Protease
Significant increase at 37°
Environmental NH Isolates

Average
Fold A

p-Value

Phenotype

Effect of temperature shift (28° to 37°)

Motility

No trend observed

0

0.336

Biofilm

No trend observed

0

0.092

Siderophore

No trend observed

0

-

Protease

Significant Decrease at 37°

2

,„;,,
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p-Value
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Figure 2.1. Cytotoxicity of clinical strains and select environmental isolates relative to reference
strain BB22. Average cytotoxicity of clinical (A) and environmental (B) towards human Caco-2
cells at 28°C (white bars) and 37°C (grey bars) relative to BB22. Cytotoxicity was determined in
four separate experiments, however given a high level of variability the values for one
representative experiment are shown (trends were consistent for the strains shown here through
out all experiments). Values represent the average of three replicates, error bars are SE. Oneway ANOVA's were performed on all strains and a significant differences relative to BB22 is
denoted by (a) for significant increase in relative cytotoxicity at 28°C, (b) for significant decrease
at 37°C, and (c) for statistically significant changes in a single strain at 37°C compared to 28°C.

29

30

60

90

120

150

Time (min)
Figure 2.2. Quantitative hemolysis by a select clinical strain
at 37°C compared to cell density. Red blood cell lysis was
determined over time, and relative hemolytic activity was
determined (OD415/OD600) for one representative strain,
MDOH-03-17282-Vp (bars), throughout the growth cycle
(black line; OD6oo)-
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Figure 2.3. Induction of the tdh promoter in clinical and
environmental strains. Promoter activity of a tdh::gfp promoter
fusion harbored in trans in a low copy number plasmid is
presented as relative fluorescence (fluorescence/OD6oo) for
various strains during maximal production (OD600 -1.0) as
determined from time course assays for cultures grown at 37°C.
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TABLE 2.SI. Virulence-associated phenotypes for environmental and clinical strains
Biofilm3

Strsin
37°d

0.08(0.02)
MDOH-03 - 0.14(0.02)
17294-Vp
0.04(0)
AQ4037
MDOH-030.03 (0)
17282-Vp
0.93(0.42)
KE9967
BB22

DAL 1094

28°

Proteaseb
37°

28°

Siderophore

Motility" 1Hemolysin

37°

28°

37°

28°

37° 28°

0.03(0)
0.09(0.02)

1.0(0) 2.0(0)
0.8(0.4) 1.0(0)

+

+

1.00
1.50

1.00 +
1.84 +

0.04(0)

0.0(0)

+

+

1.25

1.32 +

0.03(0)

1.8(0.6) 1.2(0.3) +

+

0.92

1.05 +

0.04(0.02)

1.8(0.2) 1.0(0)

+

+

1.25

1.2(0.2) 1.0(0)

+

+

1.08

1.16 +
1.79 -

1.33

0.05(0.01) 0.05(0)

0.50(0)

TX2103

0.68(0.27) 0.04(0)

2.2(0.4) 0.75(0.3)i

+

+

VP81
EnvDOH04-001
MDOH-045M732
BAC9803255
F11-3A

0.62(0.37) 0.03(0)

1.8(0.2) 0.50(0)

+

+

0.75

1.53 +
0.84 +

0.94(0.49) 0.04(0.02)

1.8(0.2) 1.0(0)

+

+

0.67

0.90 -

0.43(0.24) 0.05(0)

1.3(0.2) 0.50(0)

+

+

1.00

1.11 +

0.70(0.41) 0.03(0)

1.0(0)

+

+

1.25

1.37 -

0.44(0.20) 0.05(0)

1.3(0.3) 1.0(0)

+

+

1.08

1.16 +

Gl
G4
G6
G7
G8
G10
G12
G13
G23
G25
G26
G31
G43
G46
G61
G62
G69
G74
G79

0.04(0.02)
0.05(0)
0.04(0)
0.04(0)
0.04(0)
0.05(0)
0.06(0.02)
0.04(0)
0.04(0)
0.04(0)
0.04(0)
0.04(0)
0.03(0)
0.049(0)
0.08(0.2)
0.06(0.05)
0.03(0)
0.02(0)
0.06(0.03)

1.3(0.2)
1.2(0.2)
1.2(0.2)
1.2(0.2)
1.3(0.2)
0.5(0)
1.2(0.2)
0.8(0.2)
0.7(0.2)
0.7(0.2)
0.9(0.1)
0.8(0.2)
1.2(0.2)

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

0.74
1.00
1.16
1.16
1.00
0.84
1.05
0.95
0.95
1.37
1.37
0.95
1.63
0.90
1.11
0.79
0.84
0.84
1.00

0.75
1.00
1.08
1.17
1.04
1.08
1.08
0.75
0.92

0.03(0)
0.03(0.01)
0.04(0)
0.03(0)
0.04(0.01)
0.03(0.01)
0.06(0.02)
0.05(0)
0.04(0.01)
0.03(0)
0.05(0)
0.04(0)
0.03(0)
0.03(0)
0.04(0)
0.04(0)
0.03(0)
0.07(0.03)
0.04(0.02)

0.50(0)

2.7(0.3)
2.7(0.3)
2.7(0.3)
2.0(0.6)
3.0(0.6)
2.3(0.3)
3.0(0.6)
1.7(0.3)
2.3(0.3)
1.3(0.3)
1.3(0.3)
1.7(0.3)
3.0(0.6)
0.5(0) 2.7(0.7)
0.8(0.2) 3.0(0.6)
0.5(0)
1.3(0.3)
0.7(0.2) 2.3(0.3)
1.0(0) 2.0(0)
0.7(0.2) 2.0(0)
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1.17
1.50
1.17
1.67
1.08
1.00
0.75
0.92
0.75
1.00

-

G91
G95
G145
G149
G151
G227
G235
G237
G242
G246
G251
G255
G259
G277

0.04(0.02)
0.06(0)
0.04(0.01)
0.08(0.03)
0.09(0.03)
0.06(0.01)
0.03(0)
0.04(0.01)
0.02(0)
0.03(0)
0.03(0)
0.09(0.01)
0.09(0.04)
0.03(0)

0.04(0)
0.03(0)
0.03(0)
0.03(0)
0.04(0)
0.03(0)
0.03(0)
0.10(0.08)
0.05(0.02)
0.03(0)
0.03(0)
0.04(0.01)
0.08(0.05)
0.03(0)

0.7(.2)
1.3(0.2)
1.2(0.2)
0.7(0.2)
0.7(0.2)
1.5(0)
1.2(0.2)
1.0(0)
0.50(0)
0.6(0.1)
0.7(0.2)
0.7(0.2)
0(0)
0(0)

2.3(0.3)
2.3(0.7)
2.0(0)
1.3(0.3)
2.00(0)
2.3(0.3)
1.7(0.7)
2.7(0.3)
3.0(0)
2.7(0.3)
2.3(0.3)
1.7(0.3)
4.0(0.6)
3.7(0.3)

a

+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+

0.84
1.32
0.79
1.11
0.79
1.00
1.21
1.26
1.26
1.21
0.90
1.16
1.84
0.79

0.92
1.42
0.83
0.92
0.58
1.00
1.25
1.33
1.42
1.25
0.83
1.00
0.92
0.83

-

Biofilm formation was quantified from crystal violet staining determined at OD595
normalized by cell density of culture (OD600) for three replicates per treatment which
were averaged. The experiment was performed a total of three times and the data for one
representative experiment is presented with standard error (SE).
b
Protease was determined as the diameter of the zone of clearing around each of three
replicate spots per strain which were averaged. The experiment was performed a total of
three times and the data for one representative experiment is presented with standard
error (SE).
c
Motility is reported as velocity (mm/hr) of movement from the edge of the spotted
culture for each of three replicates, which were averaged. The experiment was performed
a total of two times and the data for one representative experiment presented. The
experiments were highly reproducible and the standard deviations for all treatments were
less than 0.01.
d
All temperatures are °C.
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CHAPTER III

GacA DIFFERENTIALLY REGULATES BACKBONE AND ACQUIRED
VIRULENCE FACTORS IN RESPONSE TO A HUMAN HOST TEMPERATURE

Although the horizontally acquired hemolysin gene tdh is a commonly used
marker for human pathogenic strains of Vibrio parahaemolyticus, little evidence exists
definitively linking this or other traits to disease. In an effort to better characterize
disease mechanisms in V. parahaemolyticus, we examined a conserved global regulator,
GacA, which regulates virulence and host association in many bacterial species including
Vibrio. A GacA mutant of V. parahaemolyticus was defective in several traits previously
associated with this regulon including protease production and metabolism. However,
other traits that may play roles in infection, including motility and biofilm formation were
uninfluenced. The mutant was defective in functional assays of virulence, including
cytotoxicity against human colon cells and disease in mice. The cytotoxicity defect
mediated by GacA was temperature dependent consistent with previous work implicating
this as an important signal in virulence in V. parahaemolyticus. In contrast to these
expected defects, the mutant also displayed a surprising hyper-hemolysis phenotype, and
microarray analysis revealed tdh and most of the VPaI-7 island was upregulated in the
mutant compared to wild-type. This was mediated by the RNA chaperone Hfq, and
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translational repressor CsrA, suggesting that some of the established regulatory circuitry
is conserved. However, unlike in some other Vibrio spp., phenotypic and transcriptional
changes did not mirror those observed in an OpaR mutant, which based on existing
paradigms was predicted to mediate GacA regulation. This work provides a foundation
for understanding regulatory changes and candidate traits required during infection.

INTRODUCTION
Despite extensive research to define virulence in Vibrio cholerae, the mechanisms
that underlie the unique infectious processes in other human pathogenic Vibrio spp., such
as Vibrio parahaemolyticus, remain elusive. Once thought to be requisite virulence
genes, thermostable direct hemolysin (tdh) and tdh-related hemolysin (trh) have been
conspicuously absent from strains involved in recent outbreaks (Garcia et al. 2009).
Though regulation of tdh is known to be under the negative control of the small RNA
chaperone protein Hfq, little is known about how this contributes to overall pathogenicity
(Nakano et al. 2008). In addition, a singular role in virulence seems unlikely as when all
copies of trh and tdh are mutated the organism remains cytotoxic, enterotoxic, and lethal
to mice indicating that these hemolysins likely act in concert with other as yet
unidentified virulence traits (Xu et al. 1994, Park et al. 2004, Hoashi et al. 1990, Hiyoshi
et al. 2010). Without a more comprehensive understanding of fundamental virulence
mechanisms in V parahaemolyticus, we lack the ability to target genetic markers of
virulence in environmental surveillance and are ill-equipped to predict and reduce
outbreaks.
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Several approaches have been employed to find candidate virulence factors for
this organism, most of which seek to identify unique gene content of clinical strains. For
example, the tdh and trh hemolyisin genes, located on VPaI-7 and Vp-PAIiH3996
respectively, were found by their association with clinical strains (Makino et al. 2003,
Okada et al. 2009). Similarly, seven key pathogenicity islands linked to a highly
infectious pandemic clone of V parahaemolyticus were discovered through comparative
genomics across several Vibrio spp. (Boyd et al. 2008). Complete genome sequencing
revealed additional putative virulence factors including exoenzyme T, cytotoxic
necrotizing factor (CNF), VPA1376 (homolog of gene found in V. cholerae pathogenicity
island), VPA1357 (protein with extensive repeats likely involved in immune evasion or
host cell attachment) and repeats in toxin (RTX), though none have been evaluated in
disease (Makino et al. 2003). Alternatively, two different type three secretion systems,
one found on chromosome I (T3SS1) and the other in a pathogenicity island on
chromosome II (T3SS2) have been investigated and are known to contribute to
cytotoxicity and enterotoxicity respectively (Park et al. 2004). However, T3SS1 is found
in all strains of V parahaemolyticus including non-pathogenic environmental isolates and
may be more important in survival in a natural habitat (Mahoney et al. 2010).
Interestingly, although T3SS2 has been linked to enterotoxicity, a T3SS2 defective strain
showed little attenuation in virulence in a mouse model (Hiyoshi et al. 2010). In
addition, increased production of these known and putative virulence associated traits in
response to a human host temperature of 37° is an important characteristic of pathogenic
strains of V parahaemolyticus (Mahoney et al. 2010). Ultimately, the inflammatory
gastroenteritis seen in human infections with V parahaemolyticus cannot be attributed to
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any single effector molecule or toxin. Pathogenicity in this organism is likely the result
of large-scale programming of virulence and colonization genes by global regulators in
response to a multitude of signals, including human host temperature (Mahoney et al.
2010).
Pathogenic and symbiotic host-microbe associations in Vibrio spp. and other gram
negative pathogens have long been known to require the GacS/GacA global regulator
(Figure 4.1) (Whistler et al. 2003, Lenz et al. 2005, Wong et al. 1998, Gauthier et al.
2010). This regulatory system coordinates expression of general colonization traits (e.g.
motility) with more specific colonization or virulence factors (e.g. toxins), even when
they have been acquired horizontally. For example, in enteropathogenic Escherichi coli,
the GacS/GacA orthologs (BarA/UvrY) control host colonization via regulation of the
locus of enterocyte effacement embedded within a pathogenicity island (Bhatt et al.
2009). Salmonella Typhimurium requires the GacS/GacA orthologs (BarA/SirA) to
properly activate transcription of the salmonella pathogenicity island-1 and therefore
invade host epithelial cells (Mizusaki et al. 2008). In the absence of a functional
GacS/GacA system, V. cholerae is unable to produce sufficient levels of the virulence
factors toxin co-regulated pilus and cholera toxin, is attenuated in virulence towards
infant mice and does not properly regulate Hap proteases (Wong et al. 1998, Jang et al.
2010, Jang et al. 2011). A gacA mutant of V vulnificus is defective in cytotoxicity,
protease, and siderophore production and virulence in mice (Gauthier et al. 2010). Even
in the beneficial association of Vibrio fischeri with its squid host GacA is required for
colonization and production of the specific symbiosis factor bioluminescence (lux), thus
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demonstrating that this two component system plays a role not just in virulence, but in
host microbe relationships in general (Whistler et al. 2003).
The mechanism by which the GacS/GacA system activates the necessary
machinery for appropriate global gene expression has been well studied (Figure 1.1).
The membrane bound sensor GacS and its cognate response regulator GacA act to relieve
repression of translation exerted by CsrA, through the production of several antagonistic
sRNA's including CsrBl/2/3/C which competitively bind CsrA (Lapouge et al. 2008). In
several Vibrio spp. studied thus far, GacS/A is intimately tied to regulation of quorum
sensing by acting upon LuxO upstream of the quorum sensing master regulator HapR in
V cholerae and LuxR in V. harveyi (Lenz et al. 2004, Tu et al. 2008). The homologous
regulator in V. parahaemolyticus (OpaR) has been under intense study for its role in
colony opacity and motility (Jaques et al. 2006, Enos-Berlage et al. 2005). The sRNA
chaperone protein host-factor lHfq (encoded by hfq) works downstream of luxO to
destabilize mRNA ofhapR and other genes in V harveyi and V cholerae, and is subject
to direct CsrA binding and repression in Escherichia coli (Lenz et al. 2004, Baker et al.
2007). Given the role that GacS/GacA is known to have in virulence in other Vibrios
spp., characterization of this regulon in V parahaemolyticus may reveal important
insights into the unique virulence mechanisms of this organism.
In the present study, we establish that GacS/GacA mediates the regulation of host
association and virulence in V parahaemolyticus, although a gacA mutation had some
unexpected effects. Consistent with its role in virulence, we expected reduced production
of known and candidate virulence factors in the GacA mutant. Indeed, the mutant was
altered in many traits, and impaired in disease in an infant mouse model for infection.
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However, in sharp contrast to its reduced virulence, the mutant displayed enhanced
hemolysis and enhanced tdh expression mediated by CsrBl, CsrA and Hfq. This work
further brings into question the role of tdh as an authentic virulence factor in this
organism. Further studies within the GacS/GacA regulon could help to identify potential
virulence mechanisms unique to this organism and to elucidate how closely related
organisms evolve to utilize the same pathways with novel outcomes.

MATERIALS AND METHODS
Bacterial strains, plasmids and culture conditions. The bacterial strains and plasmids
used in this study are listed in Table 3.1. Strains of Vibrio parahaemolyticus were
routinely grown with shaking at 37°C (or 28°C where indicated) in Heart Infusion (HI)
broth pH 7.3 which contained 12.5 g heart infusion (Fluka, Buchs, Switzerland), 20g
NaCl per liter and for plates 15g/liter granulated agar. E. coli was maintained in LuriaBertani (LB) broth. Swimming motility was assessed with plates containing 10 g
tryptone, 20 g NaCl, and 3.35 g Bacto agar per liter as previously described (Jaques et al.
2006). Swarm plates contained HI media with 10 g Bacto agar per liter. Protease activity
was measured using standard HI plates to which 4 g/L of sterilized skim milk was added
following autoclaving and cooling to 50°C. Lipase activity and exopolysaccharide
differences were evaluated qualitatively with plate assays as previously described
(Mahoney et al. 2010). Hemolysin activity was measured with Wagatsuma agar plates as
previously described (Miyamoto 1969). For carbon utilization experiments, IM media
and a single carbon source (fumurate, Casamino acids, glucose, galactose or glycerol)
were used. Tri-parental matings were performed on Super Optimal Broth (SOB) plates
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containing 2% Bactotryptone, 0.5% yeast extract, lOmM NaCl, 2.5 mM KC1, lOmM
MgCL;, lOmM MgS04 and 1.5% agar. Where required, HI media was supplemented with
antibiotics specifically, erythromycin (EM) 12 ug/ml for V. parahaemolyticus and BHI
media with 150 pg/ml for Escherichia coli and LB with chloramphenicol (CH) 25 pg/ml
or kanamycin (KM) 50 ug/ml.

Strain and plasmid construction. The low copy plasmid pEVS79 which contained the
wild-type gacA open reading frame was mutagenized using the EZ::TN<KAN-2>
insertion kit following manufacturer protocols (Epicentre, Madison,Wis.). Disruption of
the gacA gene was identified by PCR amplification and confirmed by sequence analysis.
The mutagenized gacA gene was introduced into the genome by allelic exchange as
previously described (Stabb et al. 2002). Strain JM1F3 was confirmed to have the
gacA::EZ::TN<KAN-2> mutation by sequence analysis.
Multicopy plasmids for complementation analysis were constructed by standard
methods. A gacA complementation construct was created using a plasmid pJMlD4
containing the full length gacA gene (VP1945) and was digested with PstI and Sail to
generate a 2.2kb fragment that was ligated into pV08 in the forward direction to create
pVCW9G3. An hfq complementation construct was also created by standard methods
using primers designed to the VP2817 locus of the RIMD2210633 genome. The forward
primer 5'TATTCCCGGGCGATAACAT TGAGCAGGCAC-3') and reverse primer (5'TAATGCATGCGTCTCAACCCCAG CGGAA-3') with an SphI restriction enzyme site
engineered into the 5'end were used to amplify a 683bp amplicon from BB22 genomic
DNA. The amplicon was then cloned directly into pCR®2.1-TOPO® (Invitrogen,
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Carlsbad, CA). After confirmation by sequence analysis the newly cloned hfq was
subject to a standard digest with EcoRI and ligated into the low copy number plasmid
pEVS79. Subcloning into pV08 was achieved by standard double digest of pJM3D6
with SphI and Smal to create pJM3El.

In vitro phenotypes. All phenotypic assays were done in triplicate with replicate
experiments using cultures grown in HI (EM ) when necessary and standardized to an
OD600 of 0.5 prior to inoculation. Protease, lipase and hemolysin (Wagatsuma agar)
plates were inoculated with 10 pi and incubated at 37° for 24 hours. A clearing around
the inoculum was considered a positive reaction and the diameter was measured.
Swimming motility was measured with 25ml plates inoculated with a toothpick just
below the surface of the media. After incubation at 37° measurements were taken of the
diameter at 3 hour intervals and velocity was calculated. Swarming motility was
measured using 25 ml swarm plates inoculated with 10 pi and incubated for up to 72
hours at 28°C. Biofilm production was assessed with glass tubes (12 x 75mm) inoculated
with 3 mis of HI EM and incubated at 37°C for 20 hours. An initial OD595 was taken
and cultures were dumped and incubated upside down at 80°C for 30 minutes. The tubes
were then stained with 5mls of 0.1% crystal violet for 20 minutes. Tubes were then
gently washed 4 times with dH20 then allowed to dry for 10 minutes. The tubes were
then de-stained with 5 mis of 95% EtOH and 200 pi was used to read a final OD595 in a
Tecan infinite M200 plate reader (Mannedorf, Switzerland). Biofilm production was
plotted as final ODsgs/initial OD595. An acid challenge assay and quantitative hemolysin
assay were performed as previously described (Whitaker et al. 2010, Mahoney et al.
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2010). Starvation survival was assessed by CFU counts after 24 hours of growth in HI
media. They were then normalized to CFU counts at log phase to account for the growth
defect of the gacA mutant. Oxidative stress was measured at both exponential and
stationary phase by the disk diffusion method using both bleach and H2O2. Diameters
were measured after overnight incubation at 37°C. Cytotoxicity towards human CaCo-2
cells was assessed as previously described at both 28°C and 37°C at an MOI of 100 for 4
hours (Mahoney et al. 2010).

Animal studies. An assay for induction of symptoms in an infant mouse model was
assessed as previously described (Chiang 1995). Briefly, cohorts of 6-5 day old CD-I
mice were inoculated by oral gavage with 50 pi of 1XPBS containing 106 cells of wild
type BB22 or JM1F3 or without bacteria. Each group contained 6 mice including a no
bacteria control group. The mice were monitored every hour for 24 hours or until a
change in pallor was observed at which point the mice were sacrificed. The intestines
were then aseptically harvested and homogenized in 5 mis of LB broth and plated onto
HI to determine output counts. All experiments were conducted with approval from the
Institutional Animal Care and Use Committee (IACUC Approval 08-02-05).

RNA purification. BB22 and JM1F3 were grown at both 28° and 37° in HI broth to an
OD600 of ~0.5 and immediately harvested with RNA Protect (Qiagen, Valencia, CA) for
microarray experiments. RNA was purified using an RNeasy minikit (Qiagen) following
manufacturer's instructions and cDNA synthesis for RT-PCR experiments was carried
out using a BioRad iScript cDNA Synthesis Kit (Hercules, CA, USA). For microarray
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experiments, cDNA synthesis, labeling and DNA hybridization were all performed by the
Microarray Facility at the University of California Irvine.
Microarray analysis. An Affymetrix custom 3' GeneChip containing all ORF's from
the Vibrio parahaemolyticus and Vibrio fischeri genome was designed as previously
described (Gode-Potratz et al. 2010). Gene Chip-Robust Multiarray Averaging was used
to background correct, normalize across replicate chips, and to calculate and summarize
probe level intensity. A Cyber T analysis was performed to identify differentially
expressed genes (Long et al. 2001). Only those genes with a PPDE(<p) value of > 0.90
and a fold change in gene expression of >2.0 in a gacA mutant compared to wild type in
either V.fischerior V. parahaemolyticus were selected for further analysis.

Microarray confirmation by Quantitative Real Time-PCR (qRT-PCR). Three genes
were chosen from the microarray analysis for further confirmation by quantitative real
time PCR. The tdh and spa2A genes were selected for confirmation because they were
significantly upregulated (2.4 and 4.9 fold change respectively) in agacA mutant
compared to wild type at 37°. In addition, VP2448, a putative protease, was down
regulated -3.5 fold at 37°, though it lacked strong statistical values to support this fold
change (PPDE(<p)=0.51). Despite the lack of statistical support, VP2448 was selected
for confirmation by qRT-PCR because it is annotated as a putative protease and may be
correlated with the protease defect seen in a gacA mutant. All assays were performed
twice with ±2% difference in PCR efficiency between the gene of interest and a calibrator
gene (16s). All genes of interest, including 16s, were cloned into a pCR®2.1-TOPO®
vector for use in a standard curve as a clone of interest.
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RESULTS
A gacA mutant of Vibrio parahaemolyticus is altered in multiple phenotypes. If the
function of GacA as a global virulence regulator is conserved in V. parahaemolyticus,
then the mutant should display multiple defects related to host association. Following
generation of a gac^4 ::TnKan-2 insertion mutant (JM1F3), the mutant was examined for a
suite of phenotypes representative of previously characterized GacA regulons, and
potentially involved in virulence (Table 3.2). As expected, the mutant had many general
growth and metabolic defects, including a temperature dependent growth rate phenotype.
Though no change in doubling time was detectedat 37°C (wild type= 2 hours, GacA= 2
hours), the GacA mutant had an enhanced growth rate at 28°C compared to wild type
(wild type= 3.5 hours, GacA= 2.8 hours). In addition, GacA was impaired in some traits
that may impact virulence, including starvation survival, protease, lipase, altered surface
properties (opacity and uptake of Congo red) and swarming ability. However, several
other traits that are potentially important for disease by V. parahaemolyticus, including
swimming motility, biofilm production and acid tolerance were not affected by the gacA
mutation, and oxidative resistance was only impaired in exponentially growing cells. We
observed plaque-like clearings in lawns of the GacA mutant but not the wild-type after
several days of growth consistent with the induction of a temperate phage in the absence
of GacA. Finally, the GacA mutant was less cytotoxic to human gastrointestinal cells
only at 28°C and not 37°C. All mutant phenotypes were fully complemented by the gacA
gene in trans (pVCW9G3) with the exception of growth yield, growth on single carbon
sources and swarming ability. These phenotypes were only partially complemented,
which may have resulted from cellular toxicity due to multicopy gacA. For example,
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complementation of defective growth on single carbon source agar plates was observed
but growth was weak.
The majority of GacA-phenotypes were expected given the context of previously
published GacA regulons in this and other species (Whistler et al. 2003, Lenz et al. 2005,
Wong et al. 1998, Gauthier et al. 2010). Although GacA functions upstream of the
quorum sensing regulator OpaR in multiple Vibrio sp., GacA in V. parahaemolyticus
appears not to work solely via OpaR unlike in V.fischeri(Whistler et al. 2003, Ballok
2007). Comparison with an existing OpaR mutant revealed a dramatically different
profile of phenotypes, especially swarming motility, with few in common including
opacity and cytotoxicity (Table 3.2).

The gacA mutant has a hyper-hemolysis phenotype that is mediated by CsrB, CsrA
and Hfq. Perhaps the most striking and unexpected phenotype in the GacA mutant was
the overproduction of the presumptive virulence factor hemolysin, a phenotype that was
not observed in the OpaR mutant (Table 3.3). Notably, overproduction only occurred at
37°C, and both the wild-type and GacA mutant produced very low levels of hemolysin at
28° C (data not shown). Complementation of this phenotype was not achieved with gacA
in trans (pVCW9G3), but the wild-type also exhibited enhanced hemolysis with
multicopy gacA suggesting gene dosage affects on this phenotype. As expected,
hemolysis was restored to wild type levels when the GacA mutant was complemented
with csrBl (pAEB2H8) and in the spontaneous csrA mutant JMlGl(Table 3.3).
Previous work implicates the sRNA chaperone protein Hfq in CsrA-mediated
repression in other organisms at two different junctions: CsrA directly binds to and
blocks translation of the hfq transcript in E. coli (Baker et al. 2007), and Hfq acts
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downstream of LuxO in the CsrA regulatory cascade by mediating qrr destabilization of
hapRlluxR (homologs ofopaR) (Lenz et al. 2004). In addition, hyper-hemolysis is
reported in an hfq mutant in V. parahaemolyticus (Nakano et al. 2008). Therefore,
enhanced hemolysis in the GacA mutant could be mediated via reduced Hfq levels
resulting from its sequestration by enhanced qrr 1-5 production, or via direct CsrA
repression. Indeed, a CsrA binding site (AAATAAGGAAAA) closely matching the
consensus sequence (RUACARGGAUGU) (Baker 2007) was identified in hfq and
introduction of hfq in trans (pJM3El) fully restored normal hemolysis in the GacA
mutant suggesting that reduced Hfq activity influenced this phenotype (Table 3.3.).
Notably, steady state levels of qrr 1-5 were not enhanced as one might expect based on
existing paradigms (fold change in a GacA mutant compared to wild type of qrr 1-5 with
corresponding PPDE(<p) values: 1.1 (.21), 1.5 (.34), 1.3 (.23), -1.1 (.15), -1.2 (.20)).
Additionally, hfq was not reduced significantly in the GacA mutant compared to the wildtype indicating that if GacA exerts an influence on this regulator, it does so posttranscriptionally (Table 3.Sl)(Tu et al. 2008).

GacA-mutant infected infant mice have a delay in onset of symptoms despite hyperhemolysis. If the hemolysin TDH functions as a virulence determinant, the
hyperhemolysis of the GacA mutant may enhance disease; however, we observed a
reproducible delay in the onset of diarrhea and change in pallor in GacA-mutant infected
mice compared to wild type (1.5 fold change, chi2=l 1, p-<0.001) (Figure 3.1). Bacteria
were recovered indicating that V. parahaemolyticus is able to survive and possibly
replicate in the gut (wild type input: 2xl0 5 n=l output: 7xl0 5 n=l and GacA input:
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1.8xl07 n=l output: 5.57x105 n=2 mice). Even with the consistent delayed onset of
symptoms in multiple experiments, this model was inherently variable and subtle
differences in development of mice within cohorts required that onset of symptoms and
not mortality (LD50) be used as a measure of disease. Specifically, infant mice that were
slightly more developed (exhibiting hair growth) often became symptomatic, and then
recovered when infected with either the wild type or the GacA mutant, rather than
succumbing to disease. Future work to elucidate disease may require further
optimization or an alternative model for infection.
The GacA hyper-hemolysin phenotype is attributed to upregulation of tdh (VPaI-7)
at 37°C. Regulation of virulence genes in response to human host temperatures is an
associated characteristic of clinical strains of V. parahaemolyticus (Mahoney et al. 2010).
Therefore, we examined the GacA regulon in this organism at both 28°C and 37°C to
identify GacA regulated genes that may contribute to observed phenotypes and attenuated
virulence. Arrays completed with mid-log phase cells (OD600 0.5) at 28°C revealed a
small set of genes influenced by gacA (Figure 3.2). Of the 20 genes within this group
(.41% of the overall genome), many were hypothetical proteins while others were related
to general cellular metabolism and physiology (Table 3. SI). In terms of putative
virulence gene expression, an RTX toxin (VPA1633) was upregulated in the mutant
despite the down regulation of the ABC transporters thought to be involved in RTX
export (Delepelaire et al. 2004). In comparison, examination of GacA-regulated genes at
37° revealed a sizeable regulon (202 genes or 4.2% of the overall genome) of both up and
down regulated genes (Figure 3.2 and Table 3.SI). Specifically VPaI-7 which contains
both the tdh and T3SS2 genes was significantly upregulated (2.0-7.6 fold change),
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whereas the genes immediately flanking the island were down regulated (Figure 3.3).
This increase in tdh-gene expression is consistent with the hyper-hemolysin phenotype
observed in both quantitative and qualitative assays. Interestingly, this regulatory change
is dependent on a defective GacA as there is no significant regulatory change in wild-type
VPaI-7 at 37°C compared to 28°C. This is contradictory to previous findings that
expression of a tdh-gfp gene fusions is dependent on temperature (Mahoney et al. 2010),
though the construct used in these experiments would be subject to both native
transcriptional and translational regulation. All genes in the capsular polysaccharide
(CPS) island (VPA1403-VPA1412) were down regulated in the absence of GacA unlike
VPaI-7. A small number (18 genes or 3.8% of genome) were influenced at both
temperatures (Figure 3.2).
Quantitative Real-Time PCR anlaysis confirmed the upregulation of tdh at 37°C
( 2 -AAQ =

3 0 a v e r a g e f o l d c hange;

WT 2"AACt= 0.799 SD=0.178, GacA 2"AACt= 0.198

SD-0.046) in a GacA mutant compared to wild type. The T3SS spa24 gene found within
the same pathogenicity island as tdh (VPaI-7) was also confirmed to be differentially
regulated at 37°C (2"AACt= 7.0 fold change; WT 2"AACt= 0.727 SD=0.386, GacA 2"AACt=
0.080 SD=0.037) while both tdh and spa24 were uninfluenced at 28°C in qRT-PCR
assays (tdh WT 2"AACt= 0.592 SD=0.532, tdh GacA 2"AACt= 0.523 SD=0.247 and spa24
WT 2"AACt= 0.427 SD=0.498, spa24 GacA 2"AACt= 0.152 SD=0.072. The -3.5 fold
downregulation of the putative protease VP2448 observed in the microarray studies was
not observed in qRT-PCR assays( WT 2"AACt= 0.645 SD=0.074, GacA 2"AACt= 0.776
SD=0.194), therefore this change was likely an artifact of the assay and may explain the
weak statistical values (PPDE(<p)=0.51) associated with this gene.
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DISCUSSION
In order to properly function as virulence factors, the hemolysins, and other
horizontally acquired island bound traits, must be incorporated into existing regulatory
networks to ensure coordinated and timely expression with the entirety of the cell.
Hemolysin activity and tdh-gene expression is only detected from cultures grown at
human host temperature (Mahoney et al. 2010), and microarray analysis indicates that
this response is not specific to tdh, but is a property of the majority of genes within the
VPaI-7 island. However, we only detected differences in tdh steady-state transcript
levels between the two temperatures in the absence of GacA, which leads to
overproduction of hemolysin. This suggests that temperature regulation interfaces with
GacA repression to control hemolysin and VPaI-7 island expression. Array analysis
further revealed that temperature and GacA regulation were not general attributes of all
islands. Though temperature has previously been implicated as an indirect cue in
GacS/GacA regulation in Pseudomonas fluorescens, biocontrol factors in this organism
were down regulated at higher temperatures contrary to the data shown here (Humair et
al. 2009). This work illustrates how conserved regulatory pathways evolve to selectively
include horizontally acquired genes which potentially contribute to virulence and host
association, and highlights the importance of combining comparative genomics with
functional expression analysis.
Once integrated into the conserved GacA regulon, multiple levels of regulatory
control are likely utilized by the cell to ensure proper expression of VPaI-7 and
horizontally acquired elements in general. In addition to GacA (and its downstream
regulators CsrB and CsrA), Hfq mediates the hyper-hemolysin phenotype (Table 3.3).
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Hfq is a small protein that chaperones non-coding sRNAs with the appropriate mRNA
transcripts and can act alone to influence regulation by polyadenlaytion or direct
interaction with transcripts (Valentin-Hansen et al. 2004). These interactions can either
stabilize or de-stabilize mRNA and therefore influence expression. In addition, the Hfq
protein is proposed to operate as an intermediary of communication between core and
horizontally acquired genes, likely facilitating the incorporation of horizontal elements
into existing networks such as GacA (Chao et al. 2010). Hfq also mediates the activity of
the qrr RNAs in the GacA regulon in V harveyi and has a similar hyper-hemolysin
phenotype when mutated in Vibrio parahaemolyticus (Tu et al. 2008, Nakano 2008). The
most likely model for regulation based on our data and that from other organisms is that
GacA represses hemolysin activity by relieving CsrA repression of hfq transcripts (Figure
3.3 and Figure 1.1). This results in elevated Hfq protein which lowers hemolysin activity
either by directly destabilizing the tdh transcript preventing translation, or through an
undefined and indirect mechanism (Baker et al. 2007, Nakano et al. 2008). If hemolysins
are required during infection and are produced in response to host temperature, then this
model would require that GacA either be inactivated or that repression be overridden in
vivo. Importantly, this model implicates temperature and GacA as jointly acting
regulators that converge to control hemolysin production in an additive fashion. This
dynamic process of signal interpretation and integration followed by an intricate
regulatory response, mediated by conserved circuitry yet involving newly acquired DNA,
represents a curious adaptation that may provide an advantage within a, likely
coincidental, host.
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Despite the classification of TDH as a virulence factor in V. parahaemolyticus and an
increase in hemolysin activity seen in both quantitative and qualitative assays at human
body temperature, a hyper-hemolytic GacA mutant was impaired at symptom induction
in infant mice. This was a surprising result as the entire VPaI-7 island containing the
T3SS2 thought to be involved in enterotoxicity was upregulated in the mutant. An
interpretation of this data is that TDH and hemolysin activity in general may not play as
large a role in V parahaemolyticus infections as previously thought, or alternatively that
the regulation observed in vitro does not reflect that in vivo. The delay in symptom onset
when T3SS2 is over expressed is more difficult to interpret. It is possible that overexpression of this island in general is toxic to the bacterial cell and thereby inhibits
fitness in an intestinal environment. Alternatively, GacA may not be able to effectively
colonize due to defects in other host association traits under its control and may be
inhibited from reaching the appropriate stage of infection where T3SS2 effector proteins
are most useful. Though defective at initiating disease, preliminary experiments
indicated that the GacA mutant was more resistant to complement mediated killing and
had enhanced fitness in a mouse intestine compared to wild type in a competition assay
(3-fold increased survival over wild-type based on % CFU surviving after 1 hour,
APPENDIX III and IV).
Enhanced survival with reduced symptoms may allude to important functions and
mechanisms during disease development, such as immune activation, consistent with the
inflammatory nature of gastroenteritis caused by this pathogen (Qadri et al. 2003). It is
possible that GacA was recovered in higher numbers compared to wild type because it
was better able to colonize the mouse gut but had a lack of proper symptom induction as
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a result of phenotypic defects detected in vitro. For example, a GacA mutant had
cytotoxicity, protease and lipase defects that could possibly have hindered
gastrointestinal cell death and enterotoxicity. Additionally, the GacA mutant may lack a
mucosal escape response whereby regulatory changes occur that result in the detachment
of bacterial cells from the intestine for eventual release into the external environment
(Nielson et al. 2006). As wild type cells leave the intestine at a normal rate, GacA may
accumulate in the intestine and therefore be recovered at higher numbers. Alternatively,
though wild type may induce a more potent infection, it may also be more susceptible to
the very host response that it elicits. Initial experiments showed that GacA is more
resistant to complement mediated killing (APPENDIX III). Though preliminary data,
this may point to a possible mechanism of immune evasion and may explain why fewer
wild type cells were recovered from mouse intestines despite a more potent infection.
Further analysis of gene expression within the host context, and host responses will be
essential and is an important future direction of this work.
Clearly a GacA mutation results in extensive global programming deficiencies with
far reaching implications. Differences observed in the presence/absence of unanticipated
and expected phenotypes in the GacA regulon compared to other organisms provides
further evidence that this conserved network has been rewired in this organism.
Specifically, GacA exerts its control through the regulator HapR in V cholerae
(homologous to LuxR in V harveyi, LitR V.fischeri,and OpaR in V parahaemolyticus).
However, simultaneous evaluation of an OpaR mutant of V parahaemolyticus revealed
different phenotypic profiles in comparison to GacA (Table 3.2) confirming that
organizational changes have occurred. Despite this rewiring, host association traits were
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conserved in this regulon as a GacA mutant was impaired in symptom induction in mice.
Animal experiments combined with microarray analysis of this regulon identified a
valuable subset of genes influenced by both human host temperature and GacA that may
contribute to virulence and/or colonization. Specifically, 202 genes in the GacA regulon
were influenced by temperature (37°C) (Table 3.SI). Within this cohort, a large number
of genes are downregulated, annotated as "hypothetical protein" and may be important
candidate virulence factors that could account for the defective host association of the
GacA mutant. Additionally, GacA enhanced fitness in a mouse gut could be attributed to
an upregulation of hypothetical genes within the backbone or in the horizontally acquired
VPaI-7. Given the now confirmed role in host association, characterization of the GacA
regulon could begin to clarify the unique virulence mechanisms and inflammatory host
response seen in infections of V. parahaemolyticus. Further analysis of this regulatory
cascade may help to clarify the complex mechanisms involved in the evolution of
regulatory pathways to include horizontal elements that may confer enhanced niche or
lifestyle specialization traits, and clarify the elusive virulence of this organism.

ACKNOWLEDGEMENTS
We thank Linda McCarter for kindly providing V. parahaemolyticus strains (BB22 and
OpaR). We also thank Deena Small for allowing us to perform cytotoxicity assays in her
cell culture facility and Ronald Taylor for valuable training and oversight of mouse work.

52

Table 3.1. Bacterial strains and plasmids
Strain or Plasmid

Description

E. coli strains
DH5a
F'recAl endAl hsdRllsupE44 thi-1 gyrA96
relAlA (argF-lacZYA) U169 <p80/acZM15r

Source or Reference

(Gibco-BRL, Inc.)

V. parahaemolyticus strains
LM5312 (BB22)
Wild type clinical strain tdh+ltrh(McCarter 1998)
AopaRl, BB22 derivative permanently locked in
LM5674 (OpaR)
(McCarter 1998)
translucent phase
BB22 with EZ::TN<KAN-2> insertion in gacA at
JM1F3 (GacA)
(This study)
P602 gacA::Tn, Kmr
JM1G1 (GacA;CsrA) Spontaneously arising derivative of
(This study)
JMIF3; gacA::TNKm csrA C17T GacASupl
Plasmids
pCR®2.1-TOPO®
pEVS79
pEVS104
pV08
pJMlD4
pJMlC9
pJMlC8
pVCW9G3
pJM3D4
pJM3D6
pJM3El
pAEB2H8
pJM2G5
pJM2G7
pJM2F5
pJM2H7
pJM2F8

Kmr, Apr multicopy cloning vector
(Invitrogen, Inc)
pBCSK derivative, Mob+, ChrrKmr
(Stabb 2002)
R6Ky derivative of pRK2013; AColEl, oriTtra
trb ATn903 Kmr
(Stabb 2002)
pACYC, Chr, Emr; multicopy complementation
vector
(Visick 1997)
pCR®2.1-TOPO® derivative containing 2.45kb
wild type gacA gene
(This study)
pEVS79 derivative containing 2.45kb EcoRI
fragment of gacA
(This study)
JM1C9 derivative with random EZ::TN<KAN-2>
insertion in gacA
(This study)
pV08 derivative containing 2.19kb pstl, sail
fragment of gacA from JM1C9
(This study)
Wild type putative host factor-I (hfq) in
pCR®2.1-TOPO®
(This study)
pEVS79 derivative containing hfq from pJM3D4
(This study)
pV08 derivative containing 671bp EcoRI fragment
with hfq from pJM3D6
(This study)
pV08 derivative containing csrbl from Vfischeri
(Ballok 2007)
VP16SB (16s) in pCR®2.1-TOPO® Km1, Apr
(This study)
VP1247 (serC) in pCR®2.1-TOPO® Km1, Apr
(This study)
VPA1314 (tdh) in pCR®2.1-TOPO® Kmr, Apr
(This study)
VPA1342 (putative Type III secretion protein spa24)
in pCR®2.1-TOPO® Kmr, Apr
(This study)
VP2448 (protease) in pCR®2.1-TOPO® Kmr, Apr
(This study)

Ch, chloramphenicol; Em, erythromycin; Km, kanamycin; Ap, AmpiciUin
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Table 3.2. Metabolic and virulence associated phenotypes in a gacA mutant8
Cytotoxicityb
28°
37°

Lipase

BB22
1.0(0.02) 1.0(0.36) +
JM1F3
0.6 (0.04) 0.96 (0.33 LM5674
0.7(0.02) 0.77(0.13 +
BB22+pV08
1.0(0.06) 1.0(0.27) +
JMlF3+pV08
0.079(0.16)1.0(0.08)
BB22+pVCW9G3 0.9(0.01) 1.12(0.51 +
JMlF3+pVCW9G3 1.0(0.06) 1.06(0.18 +
a
All phenotypes done at 37° unless otherwise specified
b
Fluoresence relative to BB22 (SE)
°Diameter of clearing in mm (SE)
d
diameter in mm (SE) from 5 pi bleach
e
% survival after 24 hours of growth
growth yield is maximum OD600
^values are in hours
growth on glucose, galactose, fumarate and glycerol

Protease0

Survival
Oxidation" Starvation6

Growth
Rateg
f
Yield 28° 37° Sugarsh

2.5 (0.5)
1.0(0)
24.5(1.5)
2.0 (0)
0(0)
2.0 (0)
2.0 (0)

6.0 (0)
7.3 (0.33)
7.3 (0.33)
21.3(0.67)
8.3 (0.33)
23.0(1.00)
21.0(1.00)

3.3
1.8
2.5
1.7
1.2
1.8
1.4

306%
0.28%
279%
16.6%
0.15%
10.8%
10%

3.5
2.8
3.8

2.0
2.0
2.5

+
-

+
+
-

+
+

Table 3.3. Complementation of hyper-hemolysis at 37°
Strain

Qualitative" Quantitativeb

BB22 (Wild type)

1.0

3.0 (0.01)

JM1F3 (gac :.Tn)

3.0

5.5 (0.03)

LM5674 (opaR)

2.0

3.2 (0.64)

JM1G1 (csrA, gac A ::Tn)

0.5

2.5(0.16)

BB22+pV08 (empty vector)

1.0

2.9 (0.04)

JMlF3+pV08 (empty vector)

2.0

7.0 (0.04)

BB22+pVCW9G3 (gacA in trans)

2.0

5.1 (0.20)

JMlF3+pVCW9G3 (gacA in trans)

3.0

4.5 (0.12)

BB22+pAEB2H8 (csrbl in trans)

0.5

4.3 (0.06)

JMlF3+pAEB2H8 (csrbl in trans)

1.0

2.8 (0.03)

BB22+pJM3El (hfq in trans)

0.5

4.1 (0.27)

JMlF3+pJM3El (hfq in trans)

1.0

3.3 (0.52)

Hemolysin activity was very low at 28°
a
Kanagawa Phenomenon (KP) Diameter of clearing in mm
from triplicate samples on Wagatsuma agar, SE=0
b
Absorbance (OD415) normalized by cell density (OD600) of
triplicate cultures ± (SE).
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Table 3.S1. Fold change of genes at 28° and 37° in JM1F3 compared to BB22
Locus

Fold Change
37°

VP0047
VP0048

-2.4
-6.7

VP0049
VP0050
VP0054
VP0055
VP0056
VP0111
VP0170
VP0293
VP0294
VP0294 x
VP0295
VP0296
VP0311
VP0320
VP0321
VP0321
VP0323
VP0331
VP0332
VP0355
VP0363
vp0365a
VP0366

-5.4
-2.5
2.3
2.2
2.1
-6.6
-2.2
-2.2
-2.9
-3.0
-2.7
-3.7
-2.1
-3.3
-3.7
-3.9
-2.9
-2.8
-2.4
2.0
-3.9
-2.8
-2.8

VP0376
VP0378
VP0379
VP0482
VP0484
VP0515
VP0593
VP0625
VP0629
VP0634
VP0752
VP0797
VP0817

-2.7
-4.8
-5.0
-2.6
-3.8
-2.1
-3.1
-2.7
-2.0
-2.6
-5.6
-2.8
-2.1

Annotation

28°
-6.7
-6.9

-6.1

-4.6
-3.2
-3.6
-3.0

peptide ABC transporter, ATP-binding protein
peptide ABC transporter, periplasmic peptide-binding
protein
peptide ABC transporter, permease protein
peptide ABC transporter, permease protein
hypothetical protein
putative RNA polymerase ECF-type sigma factor
hypothetical protein
hypothetical protein
putative transmembrane ABC transporter protein
sulfate adenylate transferase, subunit 1
hypothetical protein
hypothetical protein
putative sodium sulfate symporter
adenylylsulfate kinase
inorganic pyrophosphatase
conserved hypothetical protein
hypothetical protein
hypothetical protein
immunogenic protein
conserved hypothetical protein
conserved hypothetical protein
putative LuxZ
glycerol dehydrogenase GldH
putative phosphoenolpyruvate-protein
phosphotransferase (phosphotransferase system,
enzyme I)
hypothetical protein
hypothetical protein
putative ABC transporter substrate binding protein
glutamate synthase, large subunit
glutamate synthase, large subunit
conserved hypothetical protein
inositol monophosphate family protein
hypothetical protein
homocysteine synthase
hypothetical protein
conserved hypothetical protein
cysteine synthase A
selenoprotein W-related protein
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VP0842
VP0997
VP0998
VP0999

-3.0
-2.3
-3.2
-3.0

VP1011
VP1012
VP1076
VP1103
VP1252
VP1253
VP1256
VP1264
VP1318
VP1319
VP1320
VP1321
VP1322
VP1325
VP1326
VP1374
VP1433
VP1434
VP1516to
VP1517
VP1517
VP1519
VP1521
VP1751
VP1752

-2.3
-2.1

VP1861
VP1879
VP1944
VP1945 to
VP1946
VP1975
VP1999
VP2002
VP2011
VP2014
VP2015
VP2016
VP2080
VP2087
VP2088

citrate synthase
hypothetical protein
amino acid ABC transporter, ATP-binding protein
amino acid ABC transporter, periplasmic amino acidbinding protein
isocitrate dehydrogenase
cold shock-like protein CspD
hypothetical protein
alanine dehydrogenase
hypothetical protein
NifS-related protein
transporter, NadC family
hypothetical protein
putative flippase
hypothetical protein
putative CDP-ribitol pyrophosphorylase
putative dTDP-glucose 4-6-dehydratase
putative LicDl protein
hypothetical protein
hypothetical protein
putative transporter
hypothetical protein
putative VI Opilin

2.8
-2.9
-2.8
-2.2
-2.4

2.1
-3.0
-3.0
-2.9
-2.7
-2.4
-2.2
-2.3
-6.1
-2.0
-2.4

Intergenic region
putative Rhs-family protein
hypothetical protein
hypothetical protein
homoserine O-succinyltransferase
putative fimbrial biogenesis and twitching motility
protein
hypothetical protein
serine transporter
excinuclease ABC, subunit C

-3.8
-2.2
-2.9
-2.6
-4.4
-2.2
-2.5

2.3
-4.5
4.6
-3.6

19.4

3.3
-2.3

2.9
3.7
3.9
27.4
-2.2
-4.9
-3.9

13.4
156.1
-6.1
-5.5

Intergenic region
hypothetical protein
conserved hypothetical protein
hypothetical protein
tetrathionate reductase, subunit B
putative tetrathionate reductase, subunit A
putative cytochrome c
hypothetical protein
ABC transporter substrate-binding protein
oligopeptide ABC transporter, ATP-binding protein
oligopeptide ABC transporter, ATP-binding protein
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VP2089
VP2090
VP2091
VP2122
VP2201
VP2326
VP2329
VP2495
VP2544
VP2545
VP2593
VP2717
VP2761
VP2765
VP2792
VP2794
VP2795
VP2796
VP2797
VP2917
VP2918
VP3012
VPA0096
VPA0101
VPA0102
VPA0125
VPA0126
VPA0175to
VPA0176C
OMP
VPA0192
VPA0285
VPA0286
VPA0287
VPA0319 s
VPA0319
VPA0328
VPA0391 to
VPA0392
VPA0393
VPA0588
VPA0638
VPA0737
VPA0738

-2.4

oligopeptide ABC transporter, permease protein
oligopeptide ABC transporter, permease protein
oligopeptide ABC transporter, periplasmic oligopeptidebinding protein
putative channel protein
conserved hypothetical protein
acetyltransferase-related protein
efflux pump component MtrF
aconitate hydratase 2
oxaloacetate decarboxylase, alpha subunit
putative oxaloacetate decarboxylase gamma chain 1
D-3 -phosphoglycerate dehydrogenase
cobalamin-dependent methionine synthase
phosphoenolpyruvate carboxylase
cystathionine gamma-synthase
phosphoribulokinase
conserved hypothetical protein
succinylglutamate 5-semialdehyde dehydrogenase
putative arginine ornithine succinyltransferase
acetylornithine aminotransferase
hypothetical protein
hypothetical protein
hypothetical protein
outer membrane protein OmpW
hypothetical protein
putative isomerase
oxidoreductase, short-chain dehydrogenase reductase
family
putative acetyltransferase

-4.5
-2.7
4.2
5.5
4.8
3.5
4.0
-3.6

Intergenic region
tryptophanase
hypothetical protein
chaperonin, 10 kDa subunit
chaperonin, 60 kDa subunit
hypothetical protein
hypothetical protein
putative translation elongation factor G

2.2
2.7
-4.3
-2.2
2.1
2.0

Intergenic region
hypothetical protein
hypothetical protein
arginine ABC transporter, permease protein
putative two-component response regulator
putative fimbrial protein Z, transcriptional regulator

-6.5
-9.7
-2.9

-6.7
-7.8
-2.6
3.9
5.4

-12.6
-4.1
-2.3
-2.7
-3.7
-4.3
-2.5
-2.7
-2.4
-3.3
-3.8
-4.1
-7.9
-2.7
-2.5
-2.1
-2.1
-4.6
2.4
3.9
-2.9

-4.0
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VPA0851
VPA0859
VPA0933
VPA0994
VPA1000
VPA1025
VPA1027
VPA1030
VPA1031
VPA1032
VPA1033
VPA1034
VPA1035
VPA1036
VPA1037
VPA1038
VPA1039
VPA1041
VPA1042
VPA1043
VPA1044
VPA1073
VPA1204
VPA1215
VPA1278
VPA1279
VPA1314 s
VPA1323
VPA1324
VPA1328
VPA1329
VPA1331
VPA1334
VPA1335
VPA1336
VPA1339
VPA1340
VPA1341

-6.3
-2.9
2.0
3.7
3.0
-2.3
-2.8
-2.7
-3.2
-3.6
-2.8
-3.9
-3.8
-3.2
-2.6
-2.7
-2.3
-3.7
-2.9
-2.8
-3.9
-2.2
-2.1
-2.4
2.3
2.9
2.4
2.0
3.3
2.8
3.5
2.0
2.5
2.3
2.8
2.5
3.9
5.1

VPA1342
VPA1345
VPA1346
VPA1346to
VPA1347
VPA1346to

4.9
2.1
2.5

(LuxR UhpA family)
putative formate fransporter 1
putative lipase
conserved hypothetical protein
putative membrane protein
methyl-accepting chemotaxis protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
hypothetical protein
probable phosphoprotein phosphatase
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative alkaline phosphatase
acetyl-CoA acetyltransferase
hypothetical protein
hypothetical protein
diacylglycerol kinase
thermostable direct hemolysin A
hypothetical protein
hypothetical protein
hypothetical protein
putative traA protein
putative OspC2
hypothetical protein
putative type III secretion apparatus protein
hypothetical protein
putative type III secretion system EscC protein
hypothetical protein
putative Spa29, component of the Mxi-Spa secretion
machinery
putative Type III secretion protein Spa24
hypothetical protein
putative targeted effector protein YopP

2.1
2.8

Intergenic region
Intergenic region
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VPA1347
VPA1348
VPA1349
VPA1350
VPA1351
VPA1352
VPA1353
VPA1354
VPA1355
VPA1356
VPA1358
VPA1359
VPA1360
VPA1361
VPA1362
VPA1363
VPA1364
VPA1365
VPA1366
VPA1367

3.0
2.7
2.5
3.0
3.4
3.1
2.7
3.5
2.7
3.2
3.0
2.9
2.5
3.8
3.7
7.6
5.0
3.3
6.4

putative transcriptional activator ToxR
putative Type III secretion protein Spa33
hypothetical protein
hypothetical protein
hypothetical protein
putative outer membrane protein
putative type III secretion system EscU protein
putative type III secretion system EscV protein
hypothetical protein
putative dimethyladenosine transferase
hypothetical protein
hypothetical protein
hypothetical protein
putative secreted protein EspD
putative chaperone
hypothetical protein
putative two-component response regulator
hypothetical protein
putative type III secretion system lipoprotein precursor
EprK
VPA1368
7.2
hypothetical protein
VPA1370
3.3
hypothetical protein
VPA1372
3.6
hypothetical protein
VPA1380
3.2
putative OspB protein
VPA1403
-2.4
putative capsular polysaccharide biosynthesis
glycosyltransferase
VPA1404
-2.4
hypothetical protein
VPA1405
-3.9
putative polysaccharide export-related protein
VPA1406
-3.6
putative exopolysaccharide biosynthesis protein
VPA1407
-3.0
hypothetical protein
VPA1408
-2.3
putative lipopolysaccharide biosynthesis protein
VPA1409
-2.5
hypothetical protein
VPA1410
-3.4
hypothetical protein
VPA1411
-3.0
putative glycosyltransferase
VPA1412
- -2.7
hypothetical polysaccharide biosynthesis related protein
VPA1413
-2.3
hypothetical protein
VPA1432
2.3
putative two-component response regulator
VPA1444
-2.1
putative transport protein
VPA1498
-9.1
-6.7
putative L-lactate permease
VPA1499
-9.9
L-lactate dehydrogenase
VPA1609
-9.3
-5.6
proton glutamate symporter
VPA1621
2.9
hypothetical protein
All genes at both temperatures, PPDE (>p)=< 0.90
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Wild Type

Mutant

Time (hours)
Figure 3.1. Infection and onset of symptoms in mice. The GacA mutant
was delayed at initiation of symptoms in infant mice compared to wild type
(6 mice per treatment p=<0.001).

37°

28'

Figure 3.2. GacA regulon at two temperatures.
Number of genes differentially regulated at
two temperatures (28° and 37°) in a GacA mutant
compared to wild type with a PPDE (p<l) cut off
of 0.90. Out of all ORF's in the genome, 4.2% were
influenced by a GacA mutation at 37°, 0.41% at
28°, and 0.37% genes were influenced at both
temperatures.
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Figure 3.3. Heatmap of VPaI-7. The fold change of VPaI-7
and its flanking genes at 37° C in a GacA mutant compared to wild
type represented by heat map. Black represents downregulation
and white is upregluation in a microarray analysis.
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CHAPTER IV

COMPARATIVE GENOMICS AND TRANSCRIPTOMICS OF THE GacA
REGULONS IN VIBRIO FISCHERI AND VIBRIO PARAHAEMOLYTICUS REVEAL
IMPORTANT EVOLUTIONARY CHANGES AND NOVEL VIRULENCE
MECHANISMS

ABSTRACT
Vibrio spp. are closely related and share a conserved core genome that likely
allows for general aquatic survival. Genes that have been acquired horizontally by
individual species may contribute to the unique lifestyles (i.e. symbiosis or pathogenesis)
seen in Vibrio spp. A better understanding of how new genes are acquired and
assimilated into an existing and conserved host association pathway may shed light on
the process that underlies the divergence of closely related species. We propose that
exploitation of an overlapping core genome and transcriptome shared by a human
pathogen and squid symbiont will reveal insights into the evolution of species specific
host association and the emergence of novel virulence mechanisms. In this study we
utilized a combined approach of comparative genomics and transcriptomics to examine
the conserved GacA regulons in a pathogen and symbiont. V. parahaemolyticus, is an
emerging human pathogen whose virulence mechanisms are unique from other Vibrio
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spp. and are poorly characterized. Vibrio fischeri is the mutualistic symbiont of
Euprymna scolopes and shares a long evolutionary history with its host. These two
organisms were selected for comparative analysis as they are closely related but take part
in dramatically different lifestyles. This work revealed a small GacA activated
transcriptional core comprised of a majority of genes involved in central metabolism,
consistent with previously characterized GacA regulons. However several distinct
alterations specifically within the V. parahaemolyticus GacA circuitry allude to a
rewiring of this regulon to exclude biofilm and iron metabolism genes and possibly
circumvent quorum sensing machinery. This reorganization was not seen in V.fischeriin
which the GacA regulon remains intact compared to other characterized regulons. In
addition, the GacA regulon of V. parahaemolyticus had a larger subset of unique genes
(not found within the core shared by V.fischeri)including select GacA repressed
horizontally acquired genes. Unlike in the pathogenic V. parahaemolyticus, the
symbiont, V fischeri had a much smaller group of unique GacA regulated genes but had
a much larger GacA differentially regulated core. Interestingly, we observed a trend in
GacA mediated gene expression whereby genes with a %GC content lower than the
genome average (including VPaI-7 containing tdh and T3SS components) were subject to
GacA repression (while the shared core of orthologous genes were GacA activated) in the
pathogen but not in the symbiont. A fundamental understanding of how related bacteria
evolve to take part in symbiosis or pathogenesis could provide important information
regarding the evolution of novel virulence mechanisms that utilize existing cellular
circuitry.
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BACKGROUND
The family Vibrionaceae has evolved to encompass diverse species that specialize
in the occupation of specific niches and lifestyles. Bacterial host association within this
group can span from vertebrate and invertebrate symbiosis to human pathogenesis
(Thompson et al. 2004). Several of these associations have co-evolved to be highly
specific and exclusionary to other microbes. Vibrio fischeri, for example, is housed in a
specialized light organ within its mutualistic symbiont the Hawaiian Bobtail squid. This
symbiosis is initiated by a handful of cells that are able to survive a gauntlet of host
defenses, enter the light organ and induce morphological host changes that prevent any
further colonization (Whistler et al. 2003). This intimate association provides the host
with protection from predation and likely supplies a nutrient rich, protected niche for the
bacterial population (Jones et al. 2006).
In contrast to a symbiotic lifestyle, Vibrio parahaemolyticus causes gastroenteritis
when introduced into a human host. This, likely unintentional, infection occurs upon
ingestion of raw or undercooked seafood, particularly oysters (Shiraih et al. 1990).
Unlike the precision of the Vfischeri relationship with the squid, V. parahaemolyticus
does not share an extensive co-evolutionary history with its human host. Consequently,
this interaction from unintentional ingestion results in virulence facilitated by
mechanisms truly intended for an as yet unidentified natural host(s).
Despite differences in host association and outcomes, V. fischeri and V
parahaemolyticus face similar obstacles to colonization of their respective hosts. Both
species exist in a dynamic aquatic environment requiring flexibility in adaptation to
changing conditions such as fluctuations in, among others, nutrient availability,
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temperature, osmolality, and pH. During colonization, both V fischeri and V
parahaemolyticus must survive entry into the host environment and resist host immunity
within the human gut or squid light organ (Lamarcq et al. 1998). In addition, both
species must be able to effectively recognize and communicate with a suitable host and to
respond with appropriate changes in gene expression once an association has been
established. It is likely that general host association capabilities, along with conserved
central metabolic process are a function of the core "Vibrio" genome thought to support
general aquatic fitness, while host-specific functions may be reserved for genomic
material acquired horizontally (Reen et al. 2006).
Extensive work has been done to describe the genomic plasticity of Vibrios. All
members of this genera possess two chromosomes, the larger, Chromosome I is
comprised of mainly housekeeping genes and is involved in cellular survival and
reproduction. Chromosome II is smaller and appears to be the initial resting place for
DNA acquired horizontally through bacteriophage, natural competence or bacterial
conjugation (Gu et al. 2009, Han et al. 2008). For example, vibriophage was recently
found to facilitate the transfer of a major Vibrio cholerae virulence gene (CTXD) from
one strain of Vibrio cholerae to another through transduction (Choi et al. 2010). Mobile
segments of DNA including integrons, super-integrons, Integrative Conjugative
Elements, transposons, and plasmid bound genes can all be introduced by bacterial
mating or conjugative transfer. Evidence of these mobile elements can be seen
throughout the Vibrio genomes including super-integrons found in both V cholerae and
V parahaemolyticus (Rowe-magnus et al. 2001). Though rare among bacteria, Vibrio
spp. are able to take up naked DNA from the environment when in the presence of chitin
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through natural competence. This unique ability provides additional opportunities for
enhancement of existing host associations and a potential increase in the breadth of
available hosts (Meibom et al. 2005).
Although Chromosome II houses many horizontally acquired genes and is
correlated with host specificity (Izutsu et al. 2008, Boyd et al. 2008), Chromosome I is
not entirely divorced from this process. Embedded within this portion of the genome
exist important conserved regulatory mechanisms that manage not only housekeeping
genes, but also virulence and host association traits acquired horizontally (Makino et al.
2003, Ruby et al. 2005). This communication between new and old genes is critical for
coordinated gene activation and repression in response to host and environmental cues.
For example the Ler regulator found in the locus of enterocyte effacement island of
Enterohemorrhagic Escherichia coli influences both horizontally acquired and backbone
genes through relief of H-NS repression. Globally, the Ler regulator acts to integrate
acquired genes into existing virulence regulons for proper expression in response to
environmental signals (Abe et al. 2008). Additionally, in Salmonella Typhimurium, the
ancient two component regulator SirA (GacA in V. parahaemolyticus and V. fischeri)
coordinately regulates both conserved motility traits as well as acquired virulence genes
within a pathogenicity island (Goodier et al. 2001). GacA in V.fischeriand V. cholerae is
found on Chromosome I and has been linked to regulation of both conserved and
horizontally acquired genes including the Cholera Toxin (Ruby et al. 2005, Wong et al.
1998). Interestingly, colonization is mediated by GacA in both V.fischeriand V
parahaemolyticus, despite the dramatically different outcomes of host associations
(Whistler et al. 2003, Chapter III).
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In addition to GacA, a large number of conserved genes and regulatory circuitry
exist across the genus, yet Vibrio spp. utilize unique mechanisms of symbiosis and
pathogenicity within their respective host. This illustrates the possibility that orthologous
genes that have undergone subtle changes in gene expression patterns within a single
species, could contribute to novel host associations and outcomes. GacA has been tightly
linked to host association in several Vibrio spp. including, V. fischeri (Whistler et al.
2003), V. cholerae (Wong et al. 1998), V vulnificus (Gauthier er al. 2010) and V
parahaemolyticus (Chapter III), and would therefore serve as an ideal regulon to
interrogate for unique GacA mediated expression patterns that may have conferred
enhanced colonization traits. These important evolutionary changes in gene activation or
repression would not be captured by simple genomic comparisons. Therefore, a
transcriptomics approach would help to identify global changes in GacA mediated
transcriptional activation or repression and may reveal some of the resulting downstream
transcriptional changes (Hassan et al. 2010, Sahu et al. 2003). Though GacA is known to
exert its regulatory control at the level of translation, the genes in this regulon that are
subject to CsrA mediated repression may themselves be transcriptional activators or
repressors. We propose that a comparative examination of the conserved GacA regulons
in both V.fischeriand V parahaemolyticus will reveal important insights into the
regulatory mechanisms involved in each lifestyle. We theorize that both acquired and
conserved genes will be involved in both lifestyles and that unique patterns of gene
activation or repression will govern species specific host association. This approach will
provide a valuable perspective on the evolution of regulatory networks that would be
missed through comparison of genomic content alone.
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In this study we utilized both comparative genomics and comparative
transcriptomics to identify shared core and unique acquired genes potentially involved in
host association in two Vibrios that participate in different lifestyles. V fischeri strain
ESI 14 is a very well characterized mutualistic symbiont, was the first sequenced strain of
V. fischeri, and has been used in a number of microarray studies (Lupp et al. 2005, Chun
et al. 2008, Antunes et al. 2007). Though not currently sequenced, pre-pandemic V.
parahaemolyticus strain BB22 has 95% similarity to the sequenced pandemic strain
RIMD2210633, is well characterized especially for motility, is amenable to genetic
manipulation, and has also been the subject of microarray analysis (Chapter II). We
focused this study on genes regulated by the conserved GacA global regulator which
influences a variety of functions in cells, but is notably involved in host association in
both V.fischeriand V. parahaemolyticus (Whistler et al. 2003, Chapter III). Due to their
association with GacA in other organisms, some of the core genome involved in
metabolism, iron acquisition and transport, oxidative stress, motility and protease
production were expected to be GacA-regulated and part of a GacA shared core (Whistler
et al. 2003, Chapter III, Lenz et al. 2005, Wong et al. 1998, Gauthier et al. 2010, Heeb et
al. 2001, Hassan et al. 2010). However, we anticipate that some of the core genome may
be regulated in only one organism, reflective of the loss of ancient regulatory connections
in one organisms or the development of new circuitry as a result of adaptation and
specialization by each organism, specifically a GacA differentially-regulated core.
Additionally, a portion of the unique genomes, some of which are horizontally acquired
elements, is also likely to have been incorporated into this regulon deemed the GacA
unique gene regulon.
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Through direct comparison, we have defined the conserved GacA regulatory core,
and identified species-specific GacA regulated genes that may play important roles in
symbiosis and pathogenesis. We have also identified a unique GacA controlled subset of
genes that are likely to have been horizontally acquired and integrated into this conserved
regulon. This subset of genes may be relevant to virulence in V parahaemolyticus and
are ideal candidates for further evaluation for a role in host association. In addition, we
have characterized the GacA regulon in V parahaemolyticus and found that some
components have been rewired while others remain conserved alluding to the
evolutionary origin of this regulon, only some of which has remained intact in both
organisms.

METHODS
Bacterial Strains A wild type strain of Vibrio fischeri ESI 14 and Vibrio
parahaemolyticus BB22 were used as control strains in all microarray experiments. A
deletion in the gacA gene of Vibrio fischeri (VCW2F5) was created as previously
described (Whister et al. 2003). The gacA gene of Vibrio parahaemolyticus was mutated
with anEZ::TN<KAN-2> kit from Epicentre, (Madison, Wisconsin) to create JM1F3 in
previous work (Chapter III).

Microarray growth conditions and RNA purification. BB22, ESI 14, JM1F3 and
VCW2F5 were grown at both 28° and 37° in HI broth to an OD6oo of-0.5 and
immediately harvested with RNA Protect (Qiagen, Valencia, CA) as previously described
(Chapter III). RNA was purified using an RNeasy minikit (Qiagen) following
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manufacturer's instructions and cDNA synthesis, labeling and DNA hybridization were
all performed by the Microarray Facility at the University of California Irvine.

Microarray analysis. An Affymetrix custom 3' GeneChip containing all ORF's from
the Vibrio parahaemolyticus and Vibrio fischeri genome was designed as previously
described (Gode-Potratz, 2010). Gene Chip-Robust Multiarray Averaging was used to
background correct, normalize across replicate chips, and to calculate and summarize probe level
intensity. A Cyber T analysis was performed to identify differentially expressed genes
(Long et al. 2001). Only those genes with a PPDE(<p) value of > 0.90 and a fold change
in gene expression of >2.0 in a gac A mutant compared to wild type in either V. fischeri or
V. parahaemolyticus were selected for further analysis.

Identification of putative horizontally acquired elements through IslandPath
analysis. The IslandPath program identifies genes that may have been acquired
horizontally based on specific sequence signatures including, dinucleotide bias, abnormal
%G+C compared with overall genome %G+C content, proximity to transfer and
structural RNA and the presence of mobility genes (transposase and integrase) (Hsiao
2003). All genes within both chromosomes of V. parahaemolyticus and V.fischerihave
been characterized using the IslandPath program (http://www.pathogenomics.sfu.ca/
islandpath/update/IPindex.pl) and are publicly available through the IslandPath website.

RESULTS AND DISCUSSION
A combined approach of comparative genomics and transcriptomics reveals a
surprisingly small GacA-activated core shared by V. fischeri and V.
parahaemolyticus. Comparative genomics is a useful tool in the examination of existing
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genetic material across two or more organisms. This approach can reveal important
information regarding the evolutionary history of genes; specifically those acquired
horizontally or through duplication and specialization, and those lost, and can offer
valuable insight into the divergence of closely related species. A comparative genomic
analysis of V. parahaemolyticus with V.fischerirevealed a large core genome containing
3153 orthologous genes (Cooper et al. 2010), hereafter referred to as the "core genome."
This analysis compared (by BLASTp) the genomes of V parahaemolyticus and V
fischeri to establish a true Vibrio core genome that is likely essential for general survival
in an aquatic habitat. Given that GacA is highly conserved across Vibrio spp, we
expected to find many genes previously associated with this global regulator in the core
genome. Indeed, genes involved in metabolism, iron acquisition, oxidative stress,
motility and protease production were identified as part of the core genome. Though this
work defined a large number of shared genes, the remaining 1679 unique genes in V
parahaemolyticus and 649 unique genes in V.fischerirepresent a sizable group too large
to interrogate on a gene by gene basis for possible roles in symbiosis or pathogenesis. In
addition, though gene content may be exclusive to one species, this does not guarantee
that it plays a role in host association, nor does it provide any information regarding
functional expression of these genes.
Limitations in the type and breadth of analysis available from comparative
genomics can be addressed with comparative transcriptomics providing a powerful two
fold analysis of genome content and regulation. For example, detection of a newly
acquired pathogenicity island through genomics as well as characterization of its
functional expression in response to a host cue through transcriptomics can expose and
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define newly acquired virulence mechanisms. In addition, genomes with nearly identical
content can function differently as a result of subtle changes in gene activation or
repression that would be missed in stand alone genomics. Therefore, we utilized a
comparative trancriptomics approach focused on a global regulon of colonization, layered
upon the comparative genome to reveal important insights into host association,
mechanisms of specialization, and the evolution of gene networks.
Our examination of the GacA transcriptomes revealed a small set of core
orthologous genes regulated in both organisms that represents only a fraction of the core
genome (19 genes in the GacA shared core compared to 3153 in the core genome). This
is an important and more focused subset of genes that are functionally expressed in each
species and may be relevant to general aquatic survival. Given the similarities in natural
habitat, the size of the GacA shared core was unexpectedly small though the genes
present in this group were expected given other characterized regulons. The majority of
these 19 genes (Table 4.1.) are annotated as regulators or enzymes involved in central
metabolism responsible for general survival and reproduction, and many have been
identified in other GacA regulons (Wong et al. 1998, Whistler et al. 2003, Lupp et al.
2005, Lenz et al. 2005, Chun et al. 2008, Antunes et al. 2007, Gauthier et al. 2010,
Chapter III). The inclusion of central metabolism as a core component of the gacS/gacA
regulon has been confirmed by microarray analysis in many different species and genera
including, but not limited to, Vibrio (Chapter III), Pseudomonas (Hassan et al. 2010,
Girard et al. 2006), Escherichia (Sahu et al. 2003), and Xylella (Shi et al 2009). It is
important to note that GacA regulation of central metabolism has been conserved despite
other, sometimes dramatic, changes in the organization of this regulon. When Vfischeri
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and V parahaemolyticus were grown in vitro (at 28° and 37° respectively), all genes in
this regulatory core were GacA activated. This implies that the GacA shared core
supports essential cellular functions, not specific host association.
Even though only a small number of true orthologs are GacA-confrolled, further
comparisons of the transcriptomes revealed a number of genes that were annotated with
similar, if not identical, functions and so are tentatively identified as analogs (Table 4.2.).
An additional 18 genes with roles in metabolism, transport, and chemotaxis were
identified through this analysis. With the exception of the chemotaxis protein which was
GacA repressed (in both species), all other functional analogs were GacA activated;
consistent with the GacA shared core. The incorporation of analogous genes into the
appropriate regulatory network is a striking example of the efficiency and precision with
which the cell manages its regulatory components. Specifically, orthologous genes and
networks that are conserved across all Vibrio species are likely the result of a common
ancestor and have been maintained throughout evolution. However in the case of
analogous genes, the cell must be able to recognize gene function and therefore sort
analogs into the appropriately regulated networks. One interpretation of this process is
that GacA regulation can not precede function in the case of the 18 analogs identified in
this regulon and must come after the convergent evolution of function. This fascinating
and intricate system of regulatory management highlights the complex and ever changing
regulatory infrastructure of a bacterial cell. This work underscores the importance of
supplementing comparative genomics with functional analyses to identify those genes
that may lack sequence similarity or history but are analogous in function.
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In addition to the GacA shared core, we also identified two other categories of
interest within this regulon. First, a "GacA differentially regulated core" that consisted of
genes within the Vibrio core that lack a true ortholog but are still under GacA control
(Table 4.3). This group in Vfischeri consisted of 275 GacA activated and repressed
genes involved in metabolism, motility, iron acquisition and other genes common to this
regulon. In V. parahaemolyticus this group was small (96 GacA activated and repressed
genes) but had similar content to the V. fischeri group with more unannotated or
hypothetical proteins. The second category of interest was the "GacA unique gene
regulon" consisting of genes that were found only in one species and were GacA
regulated (Table 4.4). V. fischeri had 52 genes within this group while V.
parahaemolyticus had 128 genes. It is interesting to note that V. parahaemolyticus
contains a larger GacA unique gene regulon which may allude to enhanced virulence
potential or, alternatively, may reflect the loss of gene content within the Vfischeri
regulon as it has co-evolved to a mutualistic lifestyle with its squid host (Figure 4.2). A
better understanding of how these genes might have been horizontally acquired and
ultimately co-opted into the GacA regulon may reveal important information regarding
the evolution of unique lifestyles.

GacA acts as an activator of backbone genes and repressor of horizontally acquired
genes in the GacA shared core and GacA unique gene regulons. In order to better
understand how the genes of the GacA shared core and GacA unique gene regulons are
composed and regulated, we examined each group for traits associated with horizontal
gene transfer. In combination with comparative genomics and transcriptomics, an
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applied informatics analysis aimed at identifying horizontal genes based on GC content
(Island Path analysis) revealed an interesting regulatory pattern that was for the most part,
specific to the pathogen V. parahaemolyticus. Specifically, all 19 genes in the GacA
shared core regulon were GacA activated. The majority of these 19 orthologous genes
(57.9% in V.fischeriand 84.2% in V parahaemolyticus) had %GC content that was
similar to the overall genome average (respectively), in partial agreement with the
comparative genomic analysis (Table 4.5). Differences seen in the GacA shared core
reported by Cooper et al. and by an informatics approach (Islandpath program) likely
reflect differences in the techniques used to generate them. Specifically, the default
settings in Islandpath may not have been stringent enough, or the analysis based in part
on %GC content, may have been inhibited by the high %AT content of V fischeri.
However within the GacA differentially regulated cores (orthologs) we identified a
portion of genes with a %GC content differing from the genome average suggesting that
they may have been horizontally acquired. This group was larger in the symbiont (V
fischeri 42.1%) compared to the pathogen (V parahaemolyticus 15.8%). This is a
curious result given that these genes have been classified as core and are orthologous, it
may be that acquisition of these genes occurred prior to the divergence of species or may
reflect artifacts of the different parameters of the different analyses.
Despite categorization as part of the GacA unique gene regulons, just under half
of the genes in V parahaemolyticus (40.6%) and a majority in Vfischeri (69%) had
%GC content consistent with the genome average by informatics analysis. A large
majority of these genes were subject to GacA activation (88.9% in Vfischeri and 86.5%
in V. parahaemolyticus) consistent with the GacA shared core regulon. In addition, V
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parahaemolyticus had a much larger group of unique genes in the GacA regulon than V.
fischeri (54.7% and 30.5% respectively), precisely the opposite of our findings for the
GacA differentially regulated core. Interestingly, less than half of the unique genes in V.
parahaemolyticus (35.3%) whose % GC content fell below the lower limit of the overall
genome were subject to GacA activation, with the remaining 67.4% of genes under GacA
repression in contrast to the GacA activated orthologous or core genes (Table 4.5).
The specific activation or repression of backbone and horizontal genes in the
GacA regulon is an impressive example of a sophisticated bacterial response system.
GacA mediates the global activation of conserved genes involved in central metabolism
and general cell survival while repressing virulence and other acquired elements. Our
work shows that this correlated, at least in part, to differences in the % GC content of
acquired genes through a currently undefined mechanism. We propose that GacA
selectively represses virulence traits whose expression is resource intensive and too
costly for constitutive expression until the appropriate host cues are present. It is
plausible that transcriptional activation or repression directed by host signaling and
mediated by GacA, allows the cell to down regulate housekeeping genes and redirect
cellular resources towards virulence traits once in a host. We have shown that
temperature is important in this signaling, though it works additively with GacA and may
be reflective of the multi-layered tight transcriptional regulation of acquired elements.
Further analysis of the subset of genes subject to GacA repression in the V.
parahaemolyticus GacA unique gene regulon may yield important virulence and host
association factors.
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Comparative transcriptomic analysis reveals a reorganization of the conserved
GacA circuitry in V. parahaemolyticus. The conserved gacA regulon is well
characterized in a number of pathogenic and symbiotic bacterial species. Genes involved
in central metabolism, iron acquisition, motility and oxidative stress resistance are all
GacA regulated in Vibrio spp and other organisms (Whistler et al. 2003, Chapter III,
Lenz et al. 2005, Wong et al. 1998, Gauthier et al. 2010). A combined comparative
analysis of the GacA genome and transcriptome in V. parahaemolyticus and V. fischeri
revealed that a significant reorganization has occurred within the V. parahaemolyticus
regulon. Though some traits remain conserved including swarming motility, oxidative
stress and central metabolism, others appear to have been lost. Specifically, biofilm
production, iron acquisition and quorum sensing circuitries have been eliminated from
the V. parahaemolyticus regulon, yet are conserved in V.fischeri,based on microarray
analysis (Table 4.1. and Table 4.3.).
The loss of quorum sensing components in the V. parahaemolyticus GacA
regulon is particularly striking given the consistent correlation with GacA in other
organisms including V. cholerae (Tsou et al. 2011) (Table 4.6 and Figure 4.1). In V.
parahaemolyticus, quorum sensing is known to regulate expression of targeted genes
including biofilm and cytotoxicity mediated by T3SS1 on Chromosome I (Enos-Berlage
et al. 2005, Henke et al. 2004). Whereas biofilm production has historically been linked
to environmental fitness, recent work has shown that cytotoxicity as a result of T3SS1 is
may play a larger role in the natural habitat (Mahoney et al. 2010). Interestingly, T3SS2
found within the VPaI-7 island on Chromosome II is correlated with virulence and
regulated by human host temperature and GacA but not by quorum sensing machinery
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(Mahoney et al. 2010, Hyoshi et al. 2010). It appears that regulation by quorum sensing
may be more valuable for traits important in coordinated behavior that promote survival
in the natural habitat rather than in the human host. We propose that a separation of
GacA from the quorum sensing circuitry in V. parahaemolyticus may represent a
significant divergence within this regulatory network. It is possible that the GacA global
regulator has become (or is in the process of becoming) a specialized regulator of
horizontally acquired elements and therefore virulence mechanisms in V.
parahaemolyticus.

CONCLUSIONS
Subtle alterations in host association regulons such as GacA could potentially lead
to novel symbiosis or virulence mechanisms and might help to explain the emergence of
pathogens. V. cholerae, V. fischeri and V. parahaemolyticus are closely related
organisms that all contain the conserved GacA regulator, yet all have distinct virulence,
symbiosis and general host association traits (Wong et al. 1998, Whistler et al. 2003,
Chapter III). We have shown with comparative genomics and transcriptomics that while
portions of the GacA regulon are conserved in V. parahaemolyticus an obvious
reorganization resulting in the elimination of quorum sensing circuitry has occurred
(Figure 4.1). The loss of this significant connection may be indicative of an evolutionary
change in the GacA regulon whereby regulation of environmental fitness traits is lost
while management of horizontal elements and host association factors is enhanced. In
addition, differential gene activation or repression seen in the V. parahaemolyticus GacA
unique gene regulon provides an example of selective and potentially specialized GacA
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transcriptional control. The majority of unique, likely acquired genes in this group were
GacA repressed while the core elements were GacA activated. Interestingly, GacA
repression does not apply to all horizontally acquired elements but is selectively utilized
to control specific genes such as the VPaI-7 island. Overall, this work has revealed
unique evolutionary alterations in the GacA regulon in V. parahaemolyticus and
highlights the importance of conserved global regulators networks in the emergence of
novel host association mechanism.
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Table 4.1 True orthologs regulated by GacA in both Vfischeri and V. parahaemolyticus
Probe ID FoldAa Annotation
Probe ID FoldA11 Annotation
VF2528

-6.0

VP0035

-2.2

ketol-acid
reductoisomerase

-9.5

Ketol-acid reductoisomerase 2-dehydropantoate 2reductase
Dipeptide-binding protein

VF2518

VP0048

-6.7

peptide ABC transport

VF2111

-4.0

Hypothetical protein

VP0502

-2.6

hypothetical protein

VF0818

-3.8

Citrate synthase

VP0842

-3.0 * citrate synthase

VF1775

-4.4

No Annotation

VP1011

-2.3

Agglutination protein

VP1252

-2.8

VFA0769 -4.1
VF1627

-930.1 Response regulator, GacA

VP1945

19.4

VF1722

-2.4

VP1976

-2.8

VF0509

-4.1

VP2431

-2.4

VF2158

-3.2

VP2495

-2.3

VF2106

-2.5

VP2593

-4.3

VF0337

-2.9

VP2717

-2.5

VF2309

-4.3

VP2763

-2.3

VF2267

-2.5

VF2281

-9.0

VF2282

-10.2

Transcriptional activator
protein MetR
Phosphoserine
phosphatase
Aconitate hydratase 2
D-3 -phosphoglycerate
dehydrogenase
5 -methyltefrahydrofolate—
homocysteine
methyltransferase
Methylenetetrahydrofolate
reductase
Cystathionine garnmasynthase
<not provided>

Succinylglutamic
semialdehyde
dehydrogenase
VF2283
-14.7 Arginine N-succinyltransferase, beta chain
VF2284
-15.7 Acetylornithine
Aminotransferase NSUCCINYL-L,L-DAP
Aminotransferase
VF2404
Transcriptional regulator
-2.6
a
PPDE (<p) values were all >.90
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isocitrate dehydrogenase
hypothetical protein
response regulator
transcriptional
activator MetR
phosphoserine
phosphatase
aconitase
D-3 -phosphoglycerate
dehydrogenase
methionine synthase

VP2794

5,10-methylenetetrahydrofolate reductase
-2.4 cystathionine gammasynthase
-15.0 hypothetical protein

VP2795

-4.1

VP2796

-8.4

VP2797

-4.1

VP2920

-3.2

VP2765

succinylglutamic
semialdehyde
dehydrogenase
arginine
succinyltransferase
acetylornithine
aminotransferase
apoenzyme
regulator of sigma D

Table 4.2. GacA regulated analogs defined by functional similarity
Probe Set ID FoldA PPDE (<p)
ABC Transporter Components

Cold Shock Proteins
Cysteine Synthase
Homoserine-O- succinyltransferase
Methyl-accepting chemotaxis protein

Phosphoribulokinase

Proton Glutamate Symport Protein

VFA1043
VP2080 VP0379
VF1767
VP1012
VF1579
VP0797
VP1751
VF2063
VPAIOOO
VF1091
VFA0170
VFA0169
VP2792
VF0214
VF2374
VF1155
VPA1609

-2.43
-2.18
-4.96
-9.80
-2.11
-2.90
-2.80
-4.38
-4.82
2.99
2.74
3.56
5.46
-3.30
-4.52
-6.63
-2.12
-9.31

0.99
0.91
0.98
1.00
0.91
0.98
0.97
0.91
1.00
0.99
0.99
0.99
0.99
0.99
1.00
1.00
0.99
0.99

Analogous genes within the GacA regulon identified by functional
similarity expanding the GacA shared core regulon.
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Table 4.3. Orthologous genes that are GacA regulated in only one species
Probe Set ID
VP0331
VP0056
VPA0391to
VPA0392
VP0515
*VP1012
VP2011
VPA1432
*VP1751
VPA0328
VP0366

FoldA
-2.45
2.10
2,22

PPDE(<p)
0.95
0.90
0.90

Annotation
conserved hypothetical protein
hypothetical protein
Intergenic region

-2.12
-2.11
2.87
2.32
-4.38
-3.63
-2.82

0.91
0.91
0.91
0.91
0.91
0.92
0.92

VP2495
VP0293
VP0593
VP0055
VP0355
VP0629
VP1879
VP0295
•VP1011
VP0482
VPA1444
VP2765
VP0054
VP2761
VP0332
VP1516to
VP1517
VP0047
VP2717
VP1752

-2.35
-2.18
-3.07
2.17
2.02
-2.04
2.27
-2.72
-2.28
-2.57
-2.09
-2.42
2.27
-2.69
-2.36
-3.81

0.92
0.92
0.92
0.93
0.93
0.93
0.93
0.94
0.94
0.94
0.94
0.94
0.94
0.95
0.95
0.95

conserved hypothetical protein
cold shock-like protein CspD
tetrathionate reductase, subunit B
putative two-component response regulator
homoserine O-succinyltransferase
putative translation elongation factor G
putativephosphoenolpyruvate-protein
phosphotransferase (phosphotransferase system,
enzyme I)
aconitate hydratase 2
sulfate adenylate transferase, subunit 1
inositol monophosphate family protein
putative RNA polymerase ECF-type sigma factor
putative LuxZ
homocysteine synthase
serine transporter
putative sodium sulfate symporter
isocitrate dehydrogenase
glutamate synthase, large subunit
putative transport protein
cystathionine gamma-synthase
hypothetical protein
phosphoenolpyruvate carboxylase
conserved hypothetical protein
Intergenic region

-2.37
-2.45
-2.20

0.95
0.95
0.96

VP1374
VPA1039
VPA0638
VPA0588
VPA1204
VP1256
VP1434
VPA1025
VP2544
VPA1037

-6.12
-2.33
-2.21
-4.33
-2.09
-2.35
-2.40
-2.33
-2.68
-2.60

0.96
0.96
0.96
0.96
0.96
0.96
0.96
0.97
0.97
0.97

peptide ABC transporter, ATP-binding protein
cobalamin-dependent methionine synthase
putative fimbrial biogenesis and twitching
motility protein
putative transporter
hypothetical protein
arginine ABC transporter, permease protein
hypothetical protein
acetyl-CoA acetyltransferase
transporter, NadC family
putative VI Opilin
hypothetical protein
oxaloacetate decarboxylase, alpha subunit
probable phosphoprotein phosphatase
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VPA0851
VPA0101
VP0376
*VP0797
VPA0125

-6.32
2.43
-2.75
-2.80
-2.94

0.97
0.97
0.97
0.97
0.98

VPA1404
VP1999
VPA0393
VP2797
VPA0737
VPA1033
VPA1339
VPA0175to
VPA0176
VPA1034
*VP0379

-2.40
3.26
2.74
-2.72
2.11
-2.84
2.53
-4.55

0.98
0.98
0.98
0.98
0.98
0.98
0.98
0.98

-3.87
-4.96

0.98
0.98

VP1253
VPA1042
VP0050
VP1103
VPA1348
VPA0102
* VPAIOOO
VPA1041
VP0320
VPA1279
VP0170
*VP2792
VPA1324
VP0296
VP0999

-2.24
-2.89
-2.46
-2.85
3.02
3.94
2.99
-3.65
-3.30
2.87
-2.20
-3.30
3.28
-3.69
-2.98

0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99

VP1252
VPA1044
VPA0287
VPA1353
VPA1355
VP2329
VP2794
VPA1035
*VP0842
VP2015
*VP0323
VP2091

-2.75
-3.93
4.77
3.12
3.47
-4.12
-3.78
-3.79
-3.01
3.90
-2.95
-2.93

0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

putative formate transporter 1
hypothetical protein
hypothetical protein
cysteine synthase A
oxidoreductase, short-chain dehydrogenase
reductase family
hypothetical protein
conserved hypothetical protein
hypothetical protein
acetylornithine aminotransferase
putative two-component response regulator
hypothetical protein
putative type III secretion system EscC protein
Intergenic region
conserved hypothetical protein
putative ABC transporter substrate binding
protein
NifS-related protein
hypothetical protein
peptide ABC transporter, permease protein
alanine dehydrogenase.
putative transcriptional activator ToxR
putative isomerase
methyl-accepting chemotaxis protein
hypothetical protein
conserved hypothetical protein
diacylglycerol kinase
putative transmembrane ABC transporter protein
phosphoribulokinase
hypothetical protein
adenylylsulfate kinase
amino acid ABC transporter, periplasmic amino
acid-binding protein
hypothetical protein
hypothetical protein
chaperonin, 60 kDa subunit
putative outer membrane protein
putative type III secretion system EscV protein
efflux pump component MtrF
conserved hypothetical protein
conserved hypothetical protein
citrate synthase
putative cytochrome c
immunogenic protein
oligopeptide ABC transporter, periplasmic
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oligopeptide-binding protein
D-3 -phosphoglycerate dehydrogenase
excinuclease ABC, subunit C
poligopeptide ABC transporter, ATP-binding
protein
chaperonin, 10 kDa subunit
glutamate synthase, large subunit
Intergenic region

VP2593
VP1944
VP2087

-4.29
-4.53
-4.95

1.00
1.00
1.00

VPA0286
VP0484
VP1945 to
VP1946
VP2795
VP2088

5.52
-3.78
4.65

1.00
1.00
1.00

-4.11
-3.92

1.00
1.00

VP0998
*VPA1609
VP0049
*VP0048

-3.18
-9.31
-5.36
-6.71

1.00
1.00
1.00
1.00

VP2089
VP2796
VP2090
VF1427
VF1459
VF1479
VF1488
VF1506-1
VF1506-2
VF1570

-6.54
-7.94
-9.68
-9.84
-3.46
-3.89
-2.06
-4.24
-2.65
2.32

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

*VF1579
VF1585
VF1586
VF1587
VF1588
VF1593
VF1594
VF1595
VF1596
VF1597
VF 1597 to
VF1598
VF1605
VF1627
VF1644
VF1645
VF1646
VF 1646 to

-2.90
-4.07
-5.82
-8.56
-6.79
-17.70
-14.60
-30.80
-56.73
-17.76
-9.36

0.98
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

succinylglutamate 5-semialdehyde dehydrogenase
oligopeptide ABC transporter, ATP-binding
protein
amino acid ABC transporter, ATP-binding protein
proton glutamate symporter
peptide ABC transporter, permease protein
peptide ABC transporter, periplasmic peptidebinding protein
oligopeptide ABC transporter, permease protein
putative arginine ornithine succinyltransferase
oligopeptide ABC transporter, permease protein
Sulfatase family protein
Translation initiation inhibitor
Aquaporin
Aspartate aminotransferase
Iron-regulated protein FrpC, first half, RTX
Iron-regulated protein FrpC, second half
TorCAD operon transcriptional regulatory protein
TorR
Cysteine synthase
Arginine ornithine transport system protein AotM
Arginine ornithine transport system protein AotQ
Arginine-binding protein
Arginine ornithine transport ATP-binding AotP
Oligopeptide transport ATP-binding protein OppF
Oligopeptide transport ATP-binding OppD
Oligopeptide transport system permease OppC
Oligopeptide transport system permease OppB
Oligopeptide-binding protein OppA
intergenic region

-3.04
-930.08
2.15
-2.23
2.52
-2.53

1.00
1.00
1.00
1.00
1.00
1.00

Hypothetical protein
Response regulator, GacA
L-asparaginase
Aspartate-semialdehyde dehydrogenase
MALATE-2H+ LACTATE-NA+ ANTIPORTER
intergenic region
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VP1647
VF1722
VF1729
VF1730
*VF1767
VF1771
VF1772
VF1773
VF1774
*VF1775
VF 1792 to
VF1793
VF1795
VF1811
VF 1889 to
VF1890
VF1942
VF1964
VF1979
VF2059
*VF2063
VF2065
VF2104
VF2106
VF2110
VF2111
VF2116
VF2117
VF2118
VF2123 to
VF2124
VF2123 to
VF2124
VF2124
VF2125
VF2133
VF2138
VF2139
VF2140
VF2158
VF2175
VF2175 to
VF2176
VF2217
VF2218

-2.38
-2.31
-3.47
-9.80
-2.87
-3.55
-2.08
-2.24
-4.42
-2.10

1.00
1.00
1.00
1.00
1.00
1.00
0.99
1.00
1.00
1.00

Transcriptional activator protein MetR
<not provided>
Sodium proline symporter
Cold shock protein
Sensor protein kinase
Hypothetical protein
Glycosyltransferase
Stage V sporulation protein R
Isocitrate dehydrogenase [NADP]
intergenic region

2.42
-3.16
-2.79

1.00
1.00
1.00

Outer membrane protein C
3-ketoacyl-CoA thiolase
intergenic region

-2.19
-2.18
-2.93
-2.73
-4.82
11.90
-2.74
-2.53
2.81
-3.98
-4.18
-2.98
-2.80
-4.90

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

Nitrogen regulatory protein GlnK
GlnD, [protein-PII] uridylyltransferase
Transcriptional regulators, LysR family
Na(+)-linked D-alanine glycine permease
Homoserine 0-succinylfransferase
Nucleoside permease NupC
5-formyltetrahydrofolate cyclo-ligase
D-3-phosphoglycerate dehydrogenase
Na(+)-linked D-alanine glycine permease
Hypothetical protein
Threonine synthase
Homoserine kinase
Aspartokinase Homoserine dehydrogenase
intergenic region

-8.64

1.00

intergenic region

-10.88
-7.76
-2.40
-2.67
-3.59
-4.03

1.00
1.00
1.00
1.00
1.00
1.00

-3.18
-2.35
-4.23

1.00
1.00
1.00

Glutamate synthase [NADPH] large chain
Glutamate synthase [NADPH] small chain
periplasmic component of efflux system
Two-component sensor histidine kinase
Chitooligosaccharide-binding protein
Chitooligosaccharide transport system permease
protein
Aconitate hydratase 2
Hypothetical protein
intergenic region

-5.48
-7.36

1.00
1.00

Cytochrome cl
Cytochrome b
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VF2219

-8.41

1.00

VF2219_x

-8.30

1.00

VF2220

-6.38

1.00

VF2255
VF2262
VF2263
VF2266
VF2267
VF2275
VF2281
VF2282
VF2283
VF2284

-2.41
-7.67
-7.21
-2.39
-2.48
-2.07
-9.00
-10.17
-14.74
-15.74

1.00
1.00
1.00
1.00
1.00
0.99
1.00
1.00
1.00
1.00

VF2309
VF2334
VF2335
VF2336
VF2337
VF2362
*VF2374
VF2404
VF2435
VF2439
VF2516
VF2517
VF2518
VF2519

-4.33
2.41
2.74
2.99
3.07
-2.64
-6.63
-2.58
-3.08
-2.77
-4.63
-7.77
-9.55
-9.77

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

VF2520
VF2526_s

-4.33
-6.58

1.00
1.00

VF2527 x
VF2551
VF2556
VF2557
VF2558
VF2559
VF2560
VFA0005

-5.84
-5.20
-5.05
-4.80
-4.91
-4.67
-4.26
-2.07

1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.96

VFA0059
VFA0071

2.61
-5.69

1.00
1.00

Ubiquinol-cytochrome c reductase iron-sulfur
subunit
Ubiquinol-cytochrome c reductase iron-sulfur
subunit
Ubiquinol-cytochrome c reductase iron-sulfur
subunit
<not provided>
Acetolactate synthase small subunit
Acetolactate synthase large subunit
Aspartokinase Homoserine dehydrogenase
Cystathionine gamma-synthase
Transcriptional repressor CytR
<not provided>
Succinylglutamic semialdehyde dehydrogenase
Arginine N-succinyltransferase, beta chain
Aetylomithinge aminotransferase N-Succinyl-L,
L-DAP Aminotransferase
Methylenetefrahydrofolate reductase
Fumarate reductase flavoprotein subunit
Fumarate reductase iron-sulfur protein
Fumarate reductase, 15 kDa hydrophobic protein
Fumarate reductase, 13 kDa hydrophobic protein
GGDEF family protein
Phosphoribulokinase
Transcriptional regulator
Vitamin B12 receptor
Soluble pyridine nucleotide transhydrogenase
Dipeptide transport system permease,DppC
Dipeptide transport system permease, DppB
Dipeptide-binding protein
Dipeptide transport ATP-binding protein dppD
Dipeptide transport ATP-binding protein DppF
Cytochrome c5
Ketol-acid reductoisomerase -dehydropantoate 2reductase
<not provided>
Hypothetical protein
Acetolactate synthase large subunit
Hypothetical protein
Branched-chain amino acid aminotransferase
Dihydroxy-acid dehydratase
Threonine dehydratase
Peptide methionine sulfoxide reductase MsrA
MsrB
TonB-dependent outer membrane receptor
<not provided>
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VFA0072
VFA0092
VFA0106
VFA0159
VFA0160

-3.07
3.72
-3.61
-2.30
-2.10

1.00
1.00
1.00
1.00
1.00

VFA0165
*VFA0169
*VFA0170
VFA0201
VFA0272
VFA0274
VFA0283
VFA0284
VFA0285

-2.43
5.46
3.56
2.88
-2.35
-4.02
-4.76
-2.96
-3.14

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

VFA0337
VFA0338
VFA0340
VFA0345
VFA0346
VFA0347
VFA0363
VFA0378
VFA0379
VFA0380
VFA0389
VFA0394
VFA0397
VFA0475
VFA0476
VFA0507
VFA0551
VFA0583
VFA0620
VFA0695
VFA0757
VFA0758
VFA0760
VFA0761
VFA0762
VFA0763
VFA0764
VFA0767
VFA0768
VFA0769

2.62
2.82
2.61
3.86
4.78
3.25
-4.18
-4.43
-5.06
-4.70
-4.87
-2.02
2.14
2.72
2.15
4.41
-2.34
2.68
-2.53
-2.40
-9.66
-6.21
-4.52
-3.51
-3.77
-4.09
-3.54
-2.03
-3.88
-4.14

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.99
1.00
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

Sensor protein LuxQ
Aerotaxis receptor
Beta-mannosidase
Ferrichrome-binding protein
Ferrichrome transport system permease protein
FhuB
Ferric aerobactin receptor precursor
Methyl-accepting chemotaxis protein
methyl-accepting chemotaxis protein
Hypothetical protein
Integral membrane protein
Acyl-CoA desaturase
Aromatic-amino-acid aminotransferase
ATP-dependent Zn proteases
Amion-acid ABC transporter binding protein
transglycosylase
Putative ghicosyl hydrolase precursor
Putative glucosylhydrolase precursor
Amino acid permease
Amino acid permease
Evolved beta-galactosidase beta-subunit
Beta-galactosidase
Sodium proton-dependent alanine carrier protein
Glycine betaine transporter
Fusaric acid resistance protein FusE
Hypothetical protein
Methyl-accepting chemotaxis protein
Phospho-2-dehydro-3 -deoxyheptonate aldolase
<not provided>
Sensory box GGDEF family protein
Hypothetical protein
Sodium glutamate symport carrier protein
Hypothetical protein
Hypothetical protein
<not provided>
GMP reductase
Hypothetical membrane protein
Hypothetical membrane protein
Cyclopropane-fatty-acyl-phospholipid synthase
Plasmid partition protein ParA
Putative dehydrogenase
Short chain dehydrogenase
Hypothetical transcriptional regulatory protein
Cytochrome c-5 54(548)
Cysteine desulfhydrase Selenocysteine lyase
Agglutination protein
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VFA0786
VFA0794
VFA0795
VFA0799
VFA0808
VFA0816
VFA0817
VFA0818
VFA0829
VFA0830
VFA0831

-5.03
2.54
-2.04
-2.12
-2.48
-4.21
-3.77
-5.11
-2.02
-2.42
-3.92

0.98
1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.99
1.00
1.00

VFA0832
VFA1014
VFA1015
VFA1016
VFA1026
VFA1027
VFA1038
*VFA1042

-3.46
-5.68
-4.59
-4.01
-2.99
-2.19
-2.22
-2.39

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

*VFA1043
VFA1062
VFA1162-1
VFA1162-2
VFA1162to
VF1163
VFA1162to
VF1163
VFA1163
VFA1164
VFA1165

-2.43
-2.39
-4.94
-2.68
-2.73

1.00
1.00
1.00
1.00
1.00

PTS system, glucose-specific IIBC component
Acetate kinase
Two-component response regulator
Maltose maltodextrin-binding protein
1,4-alpha-glucan branching enzyme
Hypothetical protein
SC02 protein precursor
Hypothetical exported protein
Sodium proline symporter
Delta-l-pyrroline-5-carboxylate dehydrogenase
Proline dehydrogenase Delta-l-pyrroline-5carboxylate dehydrogenase
Proline dehydrogenase
Hypothetical protein
RpoS-like sigma factor
Sensory transduction protein kinase
Transcriptional regulator, LuxO family
Glycosyltransferase
Sensory box GGDEF family protein
ABC transporter component, lysophospholipase
LI transport
ABC transporter ATP-binding protein
Transporter, NRAMP family
Iron-regulated protein FrpC, first half
Iron-regulated protein FrpC, second half
intergenic region

-2.32

1.00

intergenic region

-4.64
-5.36
-2.64

1.00
1.00
1.00

VFA1166

-2.75

1.00

VFA1167
VFA1168
VFB46

-2.66
-2.42
-2.45

1.00
1.00
0.95

Type I secretion outer membrane protein
Outer membrane porin F
Type I protein secretion ATP-binding protein
Type I protein secretion transmembrane subunit
Type I secretion processing peptidase
Diguanylate cyclase phosphodiesterase domain 1
(GGDEF)
Hypothetical protein
Type I secretion adaptor protein (HlyD family)
DNA topoisomerase III
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4.4. Unique genes regulated by GacA in each species
Probe Set ID FoldA PPDEf<p^) Annotation
VPA1499
-9.85
1.00
L-lactate dehydrogenase
-9.09
VPA1498
1.00
putative L-lactate permease
VP3012
-2.15
0.97
hypothetical protein
VP2014
3.69
0.98
putative tetrathionate reductase, subunit A
27.40
VP2016
1.00
hypothetical protein
-2.15
0.84
VPA0276
putative integral membrane protein
2.09
VPA1357
0.87
hypothetical protein
-12.58
1.00
acetyltransferase-related protein
VP2326
-6.59
hypothetical protein
1.00
VP0111
-4.60
VPA0096
0.99
outer membrane protein OmpW
-3.87
0.92
VP0363
glycerol dehydrogenase GldH
-3.74
VP0321
1.00
hypothetical protein
-3.68
VP2545
0.99
putative oxaloacetate decarboxylase y chain 1
-3.57
putative exopolysaccharide biosynthesis protein
VPA1406
1.00
VPA1032
-3.55
0.97
hypothetical protein
-3.22
VPA1036
0.99
hypothetical protein
VP0294
-3.02
hypothetical protein
0.99
-3.01
VPA1411
0.98
putative glycosyltransferase
-2.96
hypothetical protein
VPA1407
0.99
-2.93
0.95
putative lipase
VPA0859
-2.91
VP0294
0.98
hypothetical protein
-2.87
hypothetical protein
VP1519
1.00
VPA1412
-2.73
0.99
hypothetical polysaccharide biosynthesis related
protein
-2.71
0.92
hypothetical protein
VPA1030
-2.69
VPA1038
0.98
hypothetical protein
VPA0192
-2.66
0.91
tryptophanase
VP0634
-2.57
0.91
hypothetical protein
-2.50
VP1861
0.90
hypothetical protein
-2.48
hypothetical protein
VPA1409
0.93
VP2917
-2.48
0.97
hypothetical protein
-2.42
putative acetyltransferase
VPA0126
0.90
-2.41
0.99
hypothetical protein
VPA1215
-2.37
VPA1403
0.98
putative capsular polysaccharide biosynthesis
glycosyltransferase
VP1326
-2.33
0.94
hypothetical protein
-2.33
hypothetical protein
VPA1413
0.97
VPA1408
-2.27
0.96
putative lipopolysaccharide biosynthesis protein
VP2002
-2.26
0.95
hypothetical protein
VP1325
-2.23
0.95
hypothetical protein
-2.18
ABC transporter substrate-binding protein
VP2080
0.91
-2.15
VPA1073
0.95
putative alkaline phosphatase
-2.08
0.92
inorganic pyrophosphatase
VP0311
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VP0817
VP1264
VPA1278
VPA1361
VPA1362
VPA1368
VPA0772
VPA1045
VPA1020
VP1410
VPA0243
VP2003
VP0365
VP1534
VPA1029
VP1235
VPA1443
VP0364
VP0752
VP0378
VPA1405
VP1975
VPA1410
VPA1031
VP1319
VP1318
VP1320
VPA1027
VPA1043
VP1321
VP0625
VP1521
VP1322
VP0997
VP1517
VP2918
VP1433
VPA1323
VPA1331
VPA1345
VPA1335
VPA1346
VPA1350
VPA1334
VPA1349
VPA1354

-2.06
2.07
2.26
2.45
3.79
7.23
-3.12
-2.14
-2.08
2.04
2.22
-2.20
-2.65
-2.29
-2.60
-3.61
-2.02
-3.06
-5.57
-4.79
-3.93
-3.64
-3.36
-3.24
-3.01
-2.95
-2.94
-2.84
-2.76
-2.70
-2.68
-2.57
-2.42
-2.33
-2.23
-2.15
-2.01
2.00
2.02
2.07
2.26
2.46
2.47
2.51
2.73
2.74

0.98
0.94
0.94
0.96
1.00
1.00
0.55
0.60
0.69
0.71
0.80
0.84
0.86
0.86
0.86
0.88
0.89
0.89
0.94
0.93
1.00
0.94
0.99
0.94
0.98
0.99
0.97
0.99
0.92
0.97
0.98
0.99
0.92
0.99
0.95
0.91
0.92
0.97
0.98
0.92
0.93
0.97
0.97
0.98
0.96
0.99

selenoprotein W-related protein
hypothetical protein
hypothetical protein
hypothetical protein
putative secreted protein EspD
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative virK protein
hypothetical protein
putative dihydroxyacetone kinase
hypothetical protein
hypothetical protein
iron-containing alcohol dehydrogenase
putative protein secretion protein
putative dihydroxyacetone kinase
conserved hypothetical protein
hypothetical protein
putative polysaccharide export-related protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative flippase
putative CDP-ribitol pyrophosphorylase
hypothetical protein
hypothetical protein
putative dTDP-glucose 4-6-dehydratase
hypothetical protein
hypothetical protein
putative LicDl protein
hypothetical protein
putative Rhs-family protein
hypothetical protein
hypothetical protein
hypothetical protein
putative OspC2
hypothetical protein
putative type III secretion apparatus protein
putative targeted effector protein YopP
hypothetical protein
hypothetical protein
putative Type III secretion protein Spa33
putative type III secretion system EscU protein
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VPA1356
VP1076
VPA1336
VPA1328
VPA1360
VPA1621
VPA1351
VPA1359
VPA1380
VPA1358
VPA1370
VPA1366
VPA1352
VPA1329
VPA0319 s
VPA1372
VPA0994
VPA1363
VPA1340
VPA0285
VPA1342
VPA1365
VPA1341

2.75
2.76
2.11
2.83
2.87
2.93
2.96
2.99
3.19
3.23
3.34
3.35
3.45
3.46
3.47
3.62
3.71
3.73
3.91
4.16
4.86
5.00
5.13

0.98
0.96
0.98
0.99
1.00
0.97
0.99
1.00
1.00
1.00
0.99
0.99
1.00
1.00
0.99
0.98
0.97
1.00
1.00
1.00
1.00
1.00
1.00

hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative OspB protein
putative dimethyladenosine transferase
hypothetical protein
hypothetical protein
hypothetical protein
putative traA protein
hypothetical protein
hypothetical protein
putative membrane protein
putative chaperone
hypothetical protein
hypothetical protein
putative Type III secretion protein Spa24
putative two-component response regulator
putative Spa29, component of the Mxi-Spa secretion
machinery
putative type III secretion system lipoprotein precursor
EprK
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
thermostable direct hemolysin A
hypothetical protein
hypothetical protein

VPA1367

6.39

1.00

VPA1364
VP2904
VPA0523
VPA0956
VPA1007
VP2962
VP1784
VP1081
VP2024
VPA1314
VPA1337
VP0321
vp0365a
VPA1346to
VPA1347
VPA1314 s
VPA1346 to
VPA1347
VPA0319
VF0710

7.56
-2.08
-3.49
-2.68
2.50
2.93
-2.07
-2.44
-3.82
2.48
2.07
-3.85
-2.82
2.11

1.00
0.51
0.54
0.59
0.60
0.61
0.77
0.82
0.85
0.86
0.89
1.00
0.92
0.97

2.44
2.83

0.92
0.97

thermostable direct hemolysin A
Intergenic region

3.96
-2.23

1.00
1.00

hypothetical protein
conserved hypothetical protein

Intergenic region
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VF0923
VF0988
VF1010
VFlOlOto
VF1011
VF1037
VF1246
VF1271
VF1273
VF1325
VF1371
VF1372
VF1377
VF1458
VF1473
VF1474
VF1493
VF1615
VF2013
VF2031
VF2033
VF2034
VF2035
VF2036
VF2036 to
VF2037
VF2043
VF2270
VFA0161
VFA0162
VFA0164
VFA0254
VFA0254 to
VF0255
VFA0339
VFA0364
VFA0406
VFA0407
VFA0473
VFA0474
VFA0480
VFA0655
VFA0693
VFA0847
VFA0885

2.08
-2.92

1.00
1.00
1.00

<not provided>
<not provided>
<not provided>

25.27
-6.02

1.00

intergenic region

-2.21
-2.13
3.15
-2.70
-2.07
-4.04
-4.15
-10.89
-3.43
-3.94
-3.64
-2.20
-2.19
-3.68
-2.02
-3.63
-3.76
-4.89
-5.43
-4.42

1.00
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.95
0.95
1.00
1.00
0.93
0.92
0.99
1.00
1.00
1.00
1.00

autoinducer synthase AinS
putative omptin family serine protease
Hypothetical membrane spanning protein
Hypothetical protein
<not provided>
Permease
Permease
Hypothetical cytosolic protein
Threonine synthase
<not provided>
putative exonuclease
<not provided>
Hypothetical protein
Probable capsid scaffolding protein
conserved hypothetical protein
hypothetical bacteriophage protein
Hypothetical protein
Hypothetical protein
possible phage regulatory protein (CII)
intergenic region

-2.50
-2.13
-2.15
-2.39
-2.18
3.34
4.28

1.00
0.94
0.98
1.00
1.00
1.00
1.00

Maltose maltodextrin-binding protein
Hypothetical protein
Aerobactin siderophore biosynthesis protein IucA
N(6)-hydroxylysine 0-acetyltransferase
L-lysine 6-monooxygenase
Hypothetical protein
intergenic region

3.02
-2.01
-5.70
-5.99
2.72
2.65
2.57
-2.03
-3.47
-4.33
-2.10

1.00
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

Probable transcriptional regulator SyrB
Transporter
Possible hydrogenase cytochrome b-type
Cytochrome c
Transcriptional regulatory protein TcpP
TcpH
<not provided>
<not provided>
<not provided>
Succinylarginine dihydrolase
Hypothetical protein
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VFA0920
VFA0921
VFA0922
VFA0923
VFA0924
VFA0925
VFA0983
VFA1017
VFA1058
VFB20
VFB21
VFB22
VFB23
VFB24
VFB25
VFB26
VFB27
VFB28
VFB29
VFB30
VFB31
VFB32
VFB37
VFB38
VFB40
VFB41
VFB42
VFB44
VFB47
VFB50

-2.88
-3.12
-4.03
-3.55
-5.51
-2.58
-5.67
-3.19
-10.92
-2.63
-3.03
-2.86
-2.58
-2.55
-2.69
-2.53
-2.47
-2.46
-2.46
-2.57
-2.38
-2.16
-2.10
-2.23
-2.45
-2.37
-2.14
-2.16
-2.53
-2.11

1.00
1.00
1.00
1.00
1.00
1.00
0.99
1.00
1.00
1.00
1.00
0.99
0.98
0.98
0.98
0.99
0.97
0.97
0.96
0.98
0.94
0.91
0.96
0.96
0.98
0.96
0.91
0.93
0.91
0.91

LuxB, luciferase beta chain
LuxA, luciferase alpha chain
LuxD. acyl transferase
LuxC, acyl-CoA reductase
Luxl, autoinducer synthesis protein
LuxR, transcriptional regulator
Hypothetical protein
Two-component response regulator
Hypothetical protein
<not provided>
<not provided>
Hypothetical protein
Hypothetical protein
Hypothetical protein
Hypothetical protein
Hypothetical protein
Hypothetical protein
Hypothetical protein
Exonuclease SbcC
Hypothetical protein
Hypothetical protein
Transporter
<not provided>
Attachment Mediating Protein VIRB2 Homolog
Channel protein VirB8
Channel protein VirB9
Channel protein VirBlO
Protein VirD4
Outer membrane protein
Relaxase

-.- ' •^•Unm'Jfi*.

94

Table 4.5. Summary of microarray and Islandpath analyses
GacA Unique Gene Regulon

GacA Shared Core

Total
Avg <Avg >Avg Total Avg
Activated
%GC %GC %GC Genes %GC
Genes
Symbiont
(V. f.)
Pathogen
(V. p.)

19

Activated

<Avg
>Avg
Repressed
Activated
%GC
%GC

11
6
2
(57%) (32%) (11%)

52

36
(69%)

88,9%

10
(19%)

90%

2
(11%)

128

52
(41%)

86.5%

63
(49%)

35.3%

6
(12%)

50%

100%
16
(84%)

1

75%

All orthologous genes in the GacA Shared Core were GacA activated and the majority fell within the average %GC,
for each organism.
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Table 4.6. Summary of GacA regulons in V parahaemolyticus and other bacteria
Altered
Host
Quorum
Motility Iron Protease Biofilm Association Sensinga Cytotoxicity
Vibrio
parahaemolyticus
c
fischeri
cholerae
e
harveyi
vulnificus
Erwinia
%
carotorva
g
chrysanthemi
s

' Salmonella
Escherichia coli
Legionella
pneumophila
8J
Pseudomonads
g
P. aeruginosa

X
X

X

X(T3SS)
X
X (T3SS)
X (T3SS)
X

X
X

X
X (T3SS)

X
X

X
X

X

X
X(T3SS)
X

X
X
X

X

X
X
X
X
X

X
X

X

X

X
X
X

X*
X*

X

-

X

X
X

Blank spaces denote "not evaluated"
- not influenced by GacA
X influenced by GacA
a
A GacA mutant of Vibrio fischeri had a very modest (and not considered biologically
relevant) influence on AHL signal production, though microarrays show a general
integration of GacA with Quorum Sensing.
Adapted from bthis study, cWhistler et al. 2003 and Chapter IV, dWong et al. 1998, Jang
et al. 2010 and Tsou 2011, eHenke et al. 2004 and Lenz et al. 2005, fGauthier et al.
2010, sLapouge et al. 2008, hGoodier et al. 2001, jBhatt et al. 2009.
J
Summary of the following species: chlororaphis(aureofaciens),entomophila,
fluorescens, marginalis syringae pv.,syringae, syringae pv. Tomato, tolaasii,
viridiflava.
•APPENDIX II
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Vibrio spp.
fischerf

harveyi cholerae* vulnificus parahaemolyticus* E.coli
S. Typhimurium8 P. aeruginosa
VarS/A
BarA/UvrY
BarA/SirA
GacS/A

• • •

I

1

0
csrB/C/D

csrB

csrB 1/2/3/

csrB 1/2/3
CsrA

z%

r0

•
0

csrB

csrB

rsmZ

CsrA

CsrA )

(^RsmA^)

Flagella
Hfq

Biofilm/
flagella

Cytotoxicity/ ^/hemolysis
Iron/protease
CT, Tcp

/
^C
HCN/
Pyocyanin

HilA/InvF/
Invasion

t

! ^r
! Lipase/Rhl

-QS (Rhl)

HapA

Figure 4.1. Summary of GacA regulatory cascades in V. parahaemolyticus and other organisms.
Annotated as GacS/GacA unless otherwise denoted, (adapted from). Dotted lines with circles represent
connections that have not been evaluated (adapted from: aBallok 2007, bLenz 2004, cJang 2011,
d
Gauthier 2010, eChapter 3, fPernestig 2003, gTeplitski 2006, hHeurlier 2004).
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V. fischeri

V parahaemolyticus

GacA shared core
•

GacA differentially regulated core

§§§

GacA regulated unique genes

Figure 4.2. Distribution of GacA-regulated genes by genomic
conservation. The GacA regulon is comprised of a small shared
core of orthologous genes, core genes regulated
in only one species and genes that are unique to species.
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CHAPTER V

DISCUSSION

Water and foodborne illnesses remain a constant problem in the United States
despite sophisticated waste water treatment facilities and extensive efforts to maintain a
sanitary food and water supply. Though multiple bacterial and viral pathogens contribute
to the steady rate of these outbreaks, infections with Vibrio spp. have increased 85% in
the last ten years (in 2009 from 1996-1998) (MMWR 2010). This alarming rise in
confirmed human cases may be the result of global climate change whereby water
temperatures slowly increase. Consequently, waters once too cold to support certain
human pathogens now provide novel habitats ideal for bacterial colonization and
persistence. In addition Vibrio spp. are well known to have a high degree of genomic
flexibility allowing rapid adaptation to fluctuating conditions or new environments (Han
et al. 2008, Gu et al. 2009, Boyd et al. 2008, Hurley et al. 2006), Therefore, detection of
Vibrio spp. in northern, historically cooler waters may be evidence of newly created
habitats, or of newly cold-adapted Vibrio spp.
V parahaemolyticus has been detected as far north as Alaska (McLaughlin et al.
2005) and is responsible for the majority of shellfish borne infections in the US (MMWR
2010).
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Surveillance projects aimed at characterizing the prevalence of V. parahaemolyticus are
ongoing in many geographic locations. However, V. parahaemolyticus is a challenging
organism to characterize and currently used clinical markers are unreliable as indicators
of virulence potential. Specifically, the classic virulence markers, tdh and trh are
sometimes absent from outbreaks or infections (Garcia et al. 2009, Bhoopong et al.
2007). In addition, we have shown that when tdh is over expressed (in a GacA mutant),
the organism is still defective in colonization of infant mice (Chapter II). This further
blurs the line between benign and pathogenic strain and likely eliminates tdh as a stand
alone virulence gene.
Unfortunately, in the absence of a dependable virulence marker, we are unable to
effectively identify pathogenic V parahaemolyticus and to therefore predict and prevent
future outbreaks. In addition, molecular detection of specific "virulence" genes provides
no information regarding their functional expression. Presence of these genes alone may
not adequately describe the pathogenic potential of a given strain. Interestingly, our work
has shown that precise regulatory patterns in response to a host cue may provide a novel
way to define virulent versus environmental strains of V. parahaemolyticus (Chapter II).
Specifically, clinical strains up-regulate several of their backbone virulence traits in
response to human host temperature (37°C) while environmental strains do not (Chapter
II). Instead of surveying strains for a specific gene, we propose that phenotypic
characterization at two temperatures would provide a suitable alternative for virulence
detection. These media based assays could be performed in a high throughput fashion to
characterize entire populations of V parahaemolyticus and would be more informative
than marker detection alone. Additionally, this approach relies on global changes within
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the cell that influence both backbone and horizontally acquired elements and may
circumvent the issue of variably present genetic markers of virulence.
Horizontal gene transfer is a major force that drives the genomic diversity in both
chromosomes of V. parahaemolyticus. The overall plasticity of the genome further
confounds efforts to identify a single genetic marker present in all clinical strains (Han et
al. 2008, Gu et al. 2009, Boyd et al. 2008, Hurley et al. 2006). Once in the cell, newly
acquired DNA must be incorporated into existing regulatory networks to ensure
coordinated expression with the entirety of the cell. Our work has shown that this is
accomplished, at least in part, through the global regulator GacA. Though conserved
across all Vibrio spp. we have shown that the GacA regulon has undergone subtle rewiring in V. parahaemolyticus compared to other characterized regulons (Chapter III and
IV). Specifically, GacA appears to simultaneously exert both positive and negative
control, mediated by CsrA, CsrB and Hfq, over conserved and horizontally acquired
elements important in metabolism and host association. Interestingly, the VPaI-7
containing tdh and T3SS is tightly regulated by both GacA repression and response to
temperature in an additive fashion (Chapter III). Therefore, V. parahaemolyticus
represents a unique model to study the evolution of regulatory networks in the context of
the GacA two component response system.
Temperature is an important cue in the regulatory transition between natural
habitat and host environment. Specifically, both backbone and acquired virulence
associated traits are upregulated at 37°C compared to 28C°. This includes the
horizontally acquired VPaI-7 which is subject to multiple layers of regulatory control.
Though incorporated into and negatively regulated by the conserved GacA network, this
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pathogenicity island is also transcriptionally activated by temperature (Chapter III) when
GacA is not functional. Interestingly, VPaI-7 contains a multitude of genes putatively
involved in human infection that have a specific response to 37°C, a temperature too high
to exist in a natural aquatic habitat. It seems curious that such a large island is
maintained in the apparent absence of continuous selective pressure, given that the time
V. parahaemolyticus actually spends in a human gut is likely far less than that in the
environment. Despite this, previous work has shown that in vivo seroconversion as a
result of an unidentified host pressure occurs in humans infected with V
parahaemolyticus (Bhoopong et al. 2007). This may be evidence that, though time in a
human gut is short, it may be sufficient to influence adaptation of this organism. In
addition, we have shown through preliminary work that the acquisition and maintenance
of this island may provide enhanced fitness within the gut (Chapter III). When VPaI-7 is
upregulated (in a GacA mutant), V parahaemolyticus displays defective pathogenesis in
mice, however in a head to head competition, the GacA mutant is more fit in a mouse gut
(APPENDIX II). It is interesting to consider that the human environment may contribute
specific selective pressure for horizontally acquired elements to be maintained.
A thorough understanding of host selective pressures and the host response to a V
parahaemolyticus infection is impeded by the lack of an adequate model system. Though
a defect in pathogenicity in a GacA mutant was detected though our work with infant
mice, ultimately this model poses inherent challenges and high levels of variability.
Infant mice lack a fully developed immune system, allowing us to artificially induce a
bacterial infection; however this results in two specific problems. First, if mice are
slightly more developed (indicated by hair growth), they become symptomatic but then
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fight off the infection and fully recover. This can lead to variability within experimental
groups and precludes the use of an LD50 as death can no longer be used as the study
endpoint. Secondly, though the lack of immunity allows bacterial colonization, it
prevents a true study of the interaction between a pathogen and the host immune system.
This makes an authentic evaluation of the dynamic process of host-microbe association
impossible. Future work to define V. parahaemolyticus infections will require a model
system that effectively mimics both the infectious process and the host response.
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PENDING REVISION. Your revision addressed the points raised by the IACUC. That
revision has been reviewed and your project has FULL APPROVAL effective 3/6/2008.
TITLE: Role of GacA in Viibrio parahaemalyticus virulence
SPECIES & QUANTITY: Mice -1132, IACUC PROTOCOL NUMBER: 08-02-05
PRINCIPAL INVESTIGATOR: Steven Fiering
INSTITUTION: Dartmouth College
FUNDING SOURCE: COBRE in Immunology, core C P20 RR15639
This Institution has an Animal Welfare Assurance on file with the Office of Laboratory
Animal Welfare. The Assurance number is A3259-01.

Sincerely,

Michele Martino, D.V.M.
For the IACUC
SNF/jlw
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APPENDIX II. Cytotoxicity of Vibrio parahaemolyticus and Vibrio fischeri.
A GacA mutation in each organism results in a loss of cytotoxic activity
towards human CaCo-2 Cells.
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APPENDIX III. Resistance to complement mediated killing in
V.parahaemolyticus.
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APPENDIX IV. Competitive colonization. Competetive survival in a mouse
intestine presented as % survival.

127

